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INTRODUCTION 
 Non communicable diseases are a major kind of disorder affecting 
all populations of the world. Globally, 54.86 million deaths were reported 
in 2013. Of which NCDs were responsible for 38.27million (70%) deaths. 
Among the various types of NCDs, circulatory diseases and 
cardiovascular illness caused 17.3 million deaths in 20131. This is a 
global data. Many cross sectional studies conducted in India. From these 
we have derived the major risk factors for CVD. This includes smoking, 
hypertension, abnormal lipids, high waist hip ratio, sedentary life style, 
psychosocial stress, lack of activity and low consumption of fruits and 
vegetables2.  
Obesity is a greatly evolving pandemic health problem. It is also 
said to be one of the most neglected health problems in the world3.It is 
defined as a state of excessive accumulation of adipose tissue mass and is 
best viewed as a syndrome or a group of diseases rather than as a single 
disease entity. High body mass has been considered as the 6th leading 
cause of burden related with disability adjusted life years (DALYs) and 
also accounting for 3 million deaths4. According to WHO, obesity is 
defined as increase in body fatness >25% for men and >35% for women5. 
In other words, it can be said as weight exceeding 10% of standard 
weight.   
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This study was chosen because obesity is a highly prevalent 
condition in our society and is associated with serious morbidity and the 
most important of which is it increases the prevalence of type 2 diabetes. 
Not too many studies were available referring obesity and its health risks 
referring South Tamilnadu particularly Tirunelveli district. So this study 
was chosen. It was done among females as obesity is more prevalent 
among them. So we took this study among them.   
Obesity is a disorder of affluent society. Majority of cases of 
obesity are due to overeating while very few accounts for endocrine 
disorders. In a world, where there is scarcity of food supply, it is 
necessary to store energy for survival in excess of what is needed for 
immediate use. Fat cells are the major energy storing sites residing within 
adipose tissue. They are distributed widely in the body. They store excess 
energy in the form of triglycerides. They also release the stored energy in 
the form of free fatty acids when the need arises for use at various sites6. 
This well orchestrated physiologic system functions through neural 
pathways and endocrine pathways and thus makes human beings to 
withstand starvation for as long as several days. But nowadays, in the 
presence of nutritional abundance in affluent society, a sedentary lifestyle 
and influence of genetic factors this system increases adipose energy 
stores and produce adverse health consequences.  
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India ranks three in the top ten countries with obese people with a 
count of 40.4 million. This shows the ongoing obesity burden to India. 
Obesity leads to many kinds of complications like heart disease, stroke, 
degenerative joint diseases, hypertension, diabetes mellitus and some 
cancers which can impair a person’s quality of life and produces a major 
burden for the society.  Among these, cardiovascular diseases produce the 
greatest morbidity and mortality 7. Obesity related mortality is mainly due 
to type 2 diabetes. All the cardiovascular disease risks are put under a 
single category called metabolic syndrome.  
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    Obesity now has a major predilection towards children and 
adolescents. This shows that the current trends will accelerate with time 
because they are the future generation. According to WHO report in 
2005, approximately 1.6 billion people were overweight and at least 400 
million adult populations were obese globally. It was also projected that 
by 2015, approximately 2.3 billion adults will be overweight and that at 
least 700 million will be obese8. The high prevalence of obesity is of 
concern in many perspectives.  
  Over the past 2 decades BMI was considered as a superior tool in 
correlating the effect of weight with morbidity and mortality. For adults, 
BMI cut-off values are age independent and same for both sexes. Obesity 
is derived differently for adults and children. Lower BMI thresholds are 
adopted for overweight and obesity for the Asia- Pacific region since this 
population has a greater risk for diabetes mellitus and abnormal lipid 
profiles even at lower body weight. 
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Universal cut off points are not appropriate for worldwide use 
because population specific and ethnic specific risks are prevailing. WHO 
Expert consultation concluded that Asian populations have a higher risk 
even at lower BMI. The cut-off point for observed risk varies from 22 to 
25kg/m2 and for higher risk starts from 26 to 31 kg/m2. BMI greater than 
23kg/m2 are said to be overweight and greater than 25kg/m2 are said to be 
obese for Asian Indians9,10.  Now many studies have shown that the risk 
of cardiovascular illness not only depend on the excess weight per se but 
rather on the location of deposition of the excess fat. BMI fails to show 
the location of fat distribution. It just signals general fat deposition.   
 In light of this, it is now found that abdominal obesity (central 
obesity or android obesity or upper body obesity) is the type of obesity 
which is most likely to be associated with an altered risk factor profile 
contributing to an increased CVD and type 2 diabetes risk, while gynoid 
obesity (or lower body obesity with fat located around the hips and 
buttocks) is seldom associated with such metabolic complications. This 
kind of central fat distribution is evident with the help of waist 
circumference. 
From the era of modern medicine, it is now possible to quantify the 
amount of adipose tissue either directly or indirectly. Intra abdominal fat 
can be more accurately quantified by dual energy X-ray absorptiometry 
(DEXA) or computed tomography (CT) or Magnetic Resonance Imaging 
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(MRI) or Ultra Sonography (USG). With the development of computed 
tomography (CT scanners), it has even been possible to clearly 
distinguish two different depots of abdominal fat:  
1) Intra-abdominal (visceral) obesity (excess fat in the abdominal 
cavity).    
2) Abdominal subcutaneous fat (the fat located just under the skin).   
Even though these imaging techniques are most effective, they are 
much expensive and complex. They cannot be adopted for routine clinical 
settings or for large population based study due to its methodological 
difficulties and its high cost. For practical purposes, we can rely on waist 
circumference (WC), WHR to predict the intra abdominal fat 
accumulation.  Our body’s overflowing excess energy is stored as fat in 
subcutaneous adipose tissue (SAT). Adiposopathy is defined as adipose 
tissue dysfunction caused by positive energy balance and sedentary life 
style in environmentally and genetically susceptible individuals. Energy 
overflow can cause accumulation of fat in various planes of our body like 
perivascular fat, myocardial fat and pericardial fat which may directly 
produce atherosclerotic cardiovascular disease.  
Thus obesity consequences are linked to the amount of intra 
abdominal fat rather than fat at other areas like buttocks and hip11. Now it 
is our duty to detect this central obesity much earlier even by using 
simpler techniques like measuring WC and it can be considered in 
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clinical practice. Thereby we can reduce some obesity related health 
burden in the society.  
 In persons between the age of 20 and 44, obesity is associated with 
four fold increase in relative risk of diabetes12. The leading cause of death 
in people with diabetes is coronary heart disease. Obesity is an 
independent risk factor for cardiovascular disease like congestive failure 
and coronary heart disease 13. This visceral obesity is associated with 
increased incidence of hypertension and atherogenic lipid profile both can 
increase the chance of cardiovascular disease 14,15. Randomized control 
trials and large observational studies have shown that increased total 
cholesterol, serum triglycerides, low density lipoproteins, and reduced 
levels of high density lipoproteins are associated with increased risk of 
CHD16. Early detection and intervention of abnormal lipid levels are 
essential to reduce CHD risk in individuals with central obesity as they 
are atherogenic. 
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AIM AND OBJECTIVES 
Aim 
To determine central obesity is the major predictor of cardiovascular 
disease risk in women 
Objectives 
 To study the prevalence of central obesity in women 
 To correlate Waist Circumference (WC) and Fasting Blood sugar 
 To correlate WC and lipid profile 
 To correlate WC and blood pressure 
 To correlate BMI with FBS, lipid profile and blood pressure 
 To detect which anthropometric measurement  had more 
correlation with these blood parameters and blood pressure 
 
 
 
 
 
 
 
 
 
 
 
REVIEW 
OF  LITERATURE 
 
 
 
9 
 
FAT AS AN ORGAN 
Adipose tissue is no longer a “neglected tissue” as the pathologist 
H.Gideon Wells presented in his well remembered article of 194017. An 
old controversy was that the adipose tissue, simply a modification of 
highly vascularised loose connective tissue which may collect fat in its 
cells18. An adult of acceptable weight is found to have 30-50 billion fat 
cells.  
EMBRYOLOGY 
Fat has a distinct origin, even though it was considered to be 
modification of connective tissue.A lentiform area of characteristic 
structure clearly separated from the surrounding connective tissue by a 
thin capsule. These bodies consist of network of capillaries and of 
mesenchymal cells. The cells are the prospective fat cells; nowhere 
except in these cells will fat appear and the entire formation will become 
a lobule of adipose tissue. The origin of these precursors of fat lobules 
can be traced back to small blood vessels; their endothelium produces the 
capillaries, while the mesenchymal adventitia spreads into the reticulum 
of the prospective fat cells. The developmental relationship between the 
anlagen of the fat cells and the blood vessels from which they derive had 
been demonstrated by Dabelow with India- ink injection of blood vessels. 
From these findings, it was concluded that the adipose tissue 
originates lobule by lobule, from the reticuloendothelial organs, which 
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are the primitive organs of the fat lobules. These are produced by reaction 
of the local vascular mesenchyme. When fat depots develop in post 
embryonic life or under pathologic conditions, the process may be 
shortened in that cells begin to store fat during the spreading of the 
mesenchyme and the formation of the capillaries, while in the embryo the 
primitive organs are maintained for a short time before fat accumulates. 
The fundamental process is the same, a reaction of the vascular 
mesenchyme without which fat depots cannot be built.  
HISTOLOGY 
Adipose tissue is collection of connective tissue in which 
adipocytes or fat cells are predominating. It is located all over the body 
constituting 15-20% of the body weight in men while in women a little 
higher. Females have approximately 50% more fat cells than men. They 
serve as storage depots for neutral fats, key regulators of the body’s 
energy metabolism.  
There are two important properties of TGL which explain their 
selection as the preferred nutrient storage in need of energy demands and 
availability.  
This includes 1) Fats are insoluble in water and they can be 
concentrated with no adverse osmotic effects on cells.  
2) The caloric density of TGL is two fold higher than proteins and 
carbohydrates.  
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Adipocytes are largely active cells. They respond to both neural 
and hormonal stimuli. It is now recognized as an important endocrine 
tissue.  It has peculiar physical properties like  poor conductor of heat and 
helps in regulating thermal insulation. It also cushions the organs and 
helps in keeping the organs in its place. 85% of total adipose tissue mass 
is found to be under the skin. It is called subcutaneous fat. This layer of 
adipose tissue helps in shaping our body and also acts as shock absorbers 
in palms and soles. And a very smaller amount is seen within the 
abdomen. This is called intra-abdominal fat. It is present in both lean and 
obese persons. It is also called as visceral fat. This includes both 
retroperitoneal fat (drains into systemic circulation) and intraperitoneal 
fat (drains into portal circulation). Mesenteric and omental fat comes 
under intraperitoneal category19. 
Adipose tissue contains matrix of connective tissues among which 
white adipocytes appear in clusters or in singles. Adipose tissue has a 
shape of a signet ring, a metal band with a jewel or stone like nucleus 
present at the top.  
Two kinds of adipose tissue are white and brown adipose tissue.  
White adipose tissue is the more common type. It is composed of 
cells that contain one very large droplet of whitish-yellow fat in their 
cytoplasm.  
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Brown adipose tissue contains abundant mitochondria and 
multiple lipid particles. It has a darker appearance and so it is called as 
brown adipose tissue. Both kinds of adipose tissue have a rich blood 
supply. 
At birth, body of human infant contains 12% fat. It increases 
rapidly during the infantile period to reach a peak of 25% by 6 months of 
age. It then declines slowly over the next 10 years to 18%. At puberty, 
there is a significant increase in fat content in females, but it falls in 
males. By 18years of age females have 25 to 28% fat content in their 
whole body. In males it falls to 15% approximately. Between ages 20 and 
50, fat content in females’ increases by 50%.  
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ADIPOSE CELLS IN OBESITY 
             The size of the adipocytes can increase up to 10 times when there 
is a need to store triglycerides. This kind of increase in fat cells is called 
as hypertrophy. 
              These increased fat sizes will bulge between strands of fibrous 
tissue producing a waffled and dimply appearance. These bulged areas 
are called cellulite. When the upper limit of fat storage is reached by 
hypertrophy then the fat cells now undergo hyperplasia. Hyperplasia 
means increase in number of cells. New adipocytes are developed from 
immature precursor cells. So an obese individual will have an increased 
number of adipocytes or enlarged adipocytes or both. They may have as 
many as 70-80billion fat cells. Once created, the number of fat cells 
cannot be reduced naturally. This is the reason why obese persons have a 
greater difficulty in losing weight once it has been achieved20. 
Liposuction is the only way by which these excess fat cells can be sucked 
out. 
From birth to early adulthood period the size of fat cells will be 
doubled or even tripled. During the infantile period, most of the size 
increases. There is no significant change in fat size thereafter until 
puberty. There is no sex difference also. At puberty the fat size increases 
in females but it is almost constant in males. There also exists a 
difference in fat cells size depending on location. Visceral fat cells are 
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smaller than subcutaneous fat cells. Not all the subcutaneous fats are of 
same size. Fats in gluteal region are larger than abdominal adipocytes 
which again is larger than sub capsular cells.  
 
OBESITY AND ITS TYPES 
    Since 1980, worldwide obesity has been doubled. As per WHO, 
obesity is defined as increase in body fatness >25% for men and >35% 
for women21. In other words, overweight and obesity are defined as 
abnormal or excessive accumulation of fat which may impair health. 
In olden days, Obesity was classified according to the mechanism 
of production as, 
1) Alimentary or exogenous obesity- due to excessive food intake 
2) Constitutional or endogenous obesity- attributed to the hereditary 
constitution of the subject. 
3) Endocrine obesity- due to disturbances in the functions of hypophysis 
(Cushing’s disease), adrenals (Cushing syndrome), thyroid 
(hypothyroidism), gonads (menopause, castration). 
4)  Obesity due to brain lesions- like those of hypothalamus. It is called 
hypothalamic obesity.   
     Usually obesity is denoted by Body Mass Index (BMI). BMI 
has limited ability to tell about body fat distribution.  Recently, the trend 
has changed towards the measure WC that can give information about 
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body fat distribution. That measurement is nothing but waist 
circumference. A person with central fat accumulation is more liable for 
cardiovascular complications. Obese persons also have psychological 
problems due to unattractive appearance and may also have sexual 
problems.  Once it was the situation at which even though the women is 
said to have a higher body fat percentage than men they have a lower risk 
for cardiovascular disease because of their pear body shape22. But a 
recent report from Obesity update 2017 delivers a fact that, obesity is 
mainly affecting women due to social inequalities.  
       So based on area of fat storage, obesity is classified into 2 
types: android (apple obesity) and gynoid (pear obesity). Recently a third 
type has been noted called, ovoid type. Dr.Jean Vague, a French 
Physician is credited with developing the terms “android” and “gynoid” 
obesity 50years ago23. 
ANDROID OBESITY 
Here fat is mainly concentrated around the abdomen, chest and 
upper arms. This kind of distribution is seen mainly among men and 
results in an apple shape or central obesity. This kind of fat distribution 
has more risk for cardio metabolic events. 
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GYNOID OBESITY 
This kind of Pear shaped physique is more common among 
women. Fat is more localized around hips, thighs.  Overweight pear 
shaped obesity leads to mechanical stress in lower half of the body.  This 
kind of obesity is less harmful because it is said that the adipose tissue in 
these areas are less metabolically active.  
OVOID OBESITY 
No differentiation between men and women kind of body fat distribution. 
This type of fat storage promotes an ‘egg shape’ fat distribution 
 
For adults, the general WHO criteria for defining overweight and obesity 
as follows: 
• Overweight is a BMI value which is greater than or equal to 25 
• Obesity is a BMI value greater than or equal to 30 
Globally, women have a higher prevalence of obesity than men24.  As the 
BMI value is same for all ages and sexes of adults, it gives more 
information about the population level measure of obese and also 
overweight. But, it should be taken as a rough measure because of the 
fact that it may correspond to the same degree of fatness in different 
people.  
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      It is logical to think that age should be considered while 
categorizing overweight and obesity. It is now said that those persons 
with increased lower body fat mass are protected from metabolic 
complications25.  
Many studies suggest that obesity can also exist even if the BMI is 
within normal limits. There is one kind of entity called “Normal Weight 
Obesity”. It is defined as a condition of having normal BMI but the 
percentage of body fat is high26. They are also called as TOFI (Thin on 
the outside fat on the Inside). TOFI are those people with BMI within 
normal limits with high intra-abdominal fat and thus more susceptible to 
DM. There is another entity called Fat fit phenotype. These people have 
greater BMI but metabolically normal27. 
At same BMI values, Asians of Indian origin tend to have 7-8% of 
higher percentage body fat than Europoids28.  
 
WAIST CIRCUMFERENCE: 
WC is a kind of measurement of perimeter of the body which gives 
an estimate of body’s circumference at the abdominal level. WC can be 
measured at different anatomical landmarks like at 1) The level of 
umbilicus 2) just below the level of lowest palpable rib 3) Just above the 
iliac crest 4) midpoint between the lowest rib and iliac crest.  The last 
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given site is usually taken as most acceptable because it is the site that has 
mainly evaluated the relationship between mortality, morbidity and 
obesity. But the site which is easily reproducible and identifiable is just 
above the iliac crest.  
                      When we consider body as a cylinder, WC measures the 
circumference of the cylinder, length is from the height of the body, 
weight is a measure of mass. BMI gives more information about body 
mass and volume whereas WC gives details about body shape. WC also 
gives IAAT and SAAT volumes 29 but cannot say its individual 
contributions for which we need CT or MRI. 
             Waist circumference is highly correlated with abdominal fat 
and is used as a marker of central obesity. Waist circumference (WC) is a 
best predictor of health outcomes in adult men and women in all age 
groups and ethnicities like African, Asian, American, Hispanics and 
Caucasians. WC is an independent predictor of diabetes than BMI30.  WC 
has a very strong correlation with diabetes risk. Cut off values for waist 
circumferences are different for different ethnicities because in some 
races like Indians a greater risk exists even at low level of BMI. These cut 
off values were derived from waist circumference that correlated with a 
BMI of 30kg/m2 or even greater31. We people like Asians tend to have a 
higher body fat percentage for the same BMI and an increased prevalence 
of cardiovascular risk at lower BMI levels than Caucasians32. Added to 
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that, at any given WC, the relative risk for mortality is higher in Asians 
than in Europeans or African Americans33. 
  World Health Organization (WHO) has indicated that threshold 
for WC which denotes increased risk in Asian population is 90cm for 
men and 80cm for women34. 
 WC and WHR are independent of height and muscle mass of the 
individual. These two things are easier to measure and calculate. WC and 
WHR showed positive correlation with myocardial infarction than 
measures of BMI35. BMI associated risk is also influenced by racial and 
ethnicity differences. When matched on BMI, the risk for diabetes is 
much higher in Southeast Asian population than Whites36. A factor that 
modifies the risk of complications related to obesity is increase in weight 
during adulthood. Weight gain of about 5 kg during 18-20 years of life, 
increases the risk of developing hypertension, diabetes, CHD37. The risk 
of developing obesity associated complications can be modified by 
exercise like aerobic fitness. This will increase the maximum oxygen 
consumption and they have lower risk for developing complications. 
They have less chance of cardiovascular mortality38.  
MRI and CT are said to be the gold standard diagnostic tests to 
evaluate the quantity of subcutaneous adipose tissue (SAAT) and Intra 
abdominal adipose tissue (IAAT) 39. In these methods cross sectional 
abdominal images are taken and then analyzed for amount of fat. The 
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most preferred level of slice to assess SAAT and IAAT is L4-L5 
intervertebral level. But it does not provide the accurate value of total 
IAAT. For this assessment should be done several centimeters above the 
level of L4-L5 space. When IAAT volume is determined at the level of 
L1-L2 than at L4-L5 the association between metabolic syndrome and 
IAAT volume is much greater40. No universally accepted site has been 
evolved.  
ANTHROPOMETRY 
Obesity is a major rising problem in India. It was found that about 
30-65% of the adults who were living in urban areas were found to be 
obese or overweight41. Anthropometry is the study of measurement of 
human body in terms of dimensions of bone, adipose tissue and muscle. 
The word anthropometry is derived from Greek word “anthropo” 
meaning human and metron meaning “measure”. Weight, stature, skin 
fold thickness, circumferences (head, waist, and limb), recumbent length, 
limb length and breadths (wrist and shoulder) are examples of 
anthropometric measures. Anthropometry is a key component of nutrition 
status assessment both in children and adults.  
It was recommended by National Heart, Lung and Blood Institute 
that as an initial assessment WC should be measured and the value of WC 
can be used to follow up the efficacy of weight loss therapy in obese and 
also in overweight patients30 
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The ideal height weight table was first released by Metropolitan 
Life Insurance Company. The major purpose of this table was to 
determine life insurance rates based on studies of life expectancies. Those 
who overweighed were rejected when they applied for life insurance. 
This table was later adopted by medical team for purpose of public 
health. The term ideal body weight denotes a person’s weight as 
compared to the weight in the ideal Height- Weight table. 
 
ASSESSMENT OF OBESITY 
1. Relative body weight: 
It is determined by the ratio of actual body weight with the 
desirable body weight in kilograms 
2. Skin fold thickness:   
It is said that at least 85% of the body fat is located subcutaneously. 
So to measure body fat content skin fold thickness (SFT) is 
commonly used. It is inexpensive, easy to use in clinical and school 
setting and non invasive. Skin callipers are used for this purpose. 
For proper report, 12 measurements should be taken at 4 different 
sites. The commonly measured sites are biceps, triceps, and 
suprailiac, sub scapular.  The three values at one site are averaged 
to give the result of that particular site. All these average values of 
the 4 sites are added together and compared with standard table to 
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determine the person’s body fat.  From the Indian data, studies 
suggest that SFT greater than 95th percentile to be considered as 
obese42.  
3. Body Mass Index(BMI) or Quetelet’s index:  
It is the value obtained by dividing the actual body weight in 
kilograms by the height of the body in square meters.  BMI is not 
used for body builders, pregnant women, elderly, long distance 
athletes and young children. 
4. Waist Hip Ratio(WHR): 
It is the ratio obtained by dividing the circumference in centimetres 
of waist by the circumference in centimetres of hip. 
5. Corpulence Index:  
It is determined by dividing actual body weight by desirable body 
weight. 
It should exceed 1.2 to say as obese 
6. Broca’s Index: 
Height of the body in centimetres- 100= Ideal weight.  
 
 
 
 
 
 SKIN FOLD THICKNESS 
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We have already discussed in detail about the waist circumference. 
Percent reasonable body weight: 
• Overweight: 10 to 20% above the reasonable body weight 
• Obese: more than 20% above the reasonable body weight 
The obese persons can be classified further as  
• Mildly obese: 20-40% overweight 
• Moderately obese: 41 to 100% overweight 
• Severe (extremely): greater than 100% overweight 
 
OTHER TECHNIQUES OF BODY COMPOSITION 
ASSESSMENT: 
                 In the olden days, cadavers were dissected and studied about 
the body fat composition. But this technique is much difficult and 
problematic. Now, many new methods are available which includes 
hydrometry or dilution to determine total body water(TBW),  
densitometry (hydrostatic weight and air displacement plethysmography), 
dual energy X-Ray absorptiometry,  computed tomography, magnetic 
resonance imaging, nuclear techniques like whole body counting of 
potassium 40 or neuron activation,  ultrasound, total body electrical 
conductivity. All these investigations give more accurate value of body 
fat mass than the manual methods of measurement.   
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But all these procedures are costlier and cumbersome to be used. 
Accurate results are achieved with experienced hands only. The 
bioelectric Impedance Analysis evaluates body composition by 
measuring the distribution of fat in different parts of the body, 
differentiating them into tissue and fluid compartments. In athletic clubs 
and gyms electrical impedance is widely used. Subcutaneous fat often 
hinders heat loss by irradiation, and for this reason obese subjects 
perspire more than thin ones.  
 
BIOLOGICAL MECHANISMS RESPONSIBLE FOR THE 
ASSOCIATION BETWEEN WC AND CARDIOMETABOLIC 
RISK 
The relationship cannot be concluded with a single hypothesis. Many 
things are put forwarded to show their association.  
 One of the earliest hypothesis which shows IAAT as a metabolic 
risk factor is that due to environmental stressors, central nervous 
system and adrenal axis gets activated producing preferential 
deposition of fat in the trunk areas and cardio metabolic disorders 
associated with that deposition43.   
 Another hypothesis is that subcutaneous tissue has limited ability 
to store excess energy. So whatever excess energy present will 
overflow to IAAT and ectopic energy storing sites like skeletal 
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muscle and liver. Excessive accumulation of fat in these ectopic 
sites produces metabolic dysfunction in such organs. Increased 
intrahepatic fat produce hepatic insulin resistance and also 
dyslipidemia44. Increased intra myocellular fat produce insulin 
resistance in skeletal muscle. From this statement we can say that 
IAAT is an index for overflow of fatty acids from subcutaneous 
adipose tissue. 
  Metabolic products of omental and mesenteric fat tissue are 
released into portal vein which is directed towards the liver. These 
products produce hepatic insulin resistance and also provide 
substrate for synthesis of lipoproteins. The omental and mesenteric 
fat also produces certain hormones contributing to cardio metabolic 
risk. 
 Fourth hypothesis is that, in some people there are presence of 
certain genes which causes preferential fat deposition in the 
abdominal areas can alone cause cardio metabolic risk. 
PATHOGENESIS OF OBESITY 
ENERGY BALANCE: 
The major fundamental cause of obesity and overweight is an 
imbalance between calories consumed and calories expended. 
Worldwide, there has been an increased intake of dense energy foods that 
are high in fat content.  Gastrointestinal tract has the capacity to absorb 
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large quantity of nutrients. In 1 year, only 5% increase in caloric intake 
than energy expenditure will lead on to 5kg increase in weight in adipose 
tissue.  
ROLE OF HORMONES: 
                      Body weight regulation is also coordinated by hormones 
and neuronal circuit. When there is food deprivation, appetite increases, 
energy expenditure gets reduced. Similarly, when there is over feeding, 
appetite decreases, energy expenditure has to be increased. But the latter 
does not happen, instead over feeding leads to overweight and obesity 
when food is abundant and physical activity is limited. 
              A major hormone regulating these adaptations is LEPTIN, 
which is an adipocyte derived hormone. Other major hormonal signals 
are insulin, gut peptides and cortisol. Neuropeptide YY, Agouti related 
peptide, Melanocyte concentrating hormone, cortisol, Ghrelin all these 
hormones stimulate appetite. MSH, Leptin, will decrease appetite. 
Another hormone which needs special mention is Peptide tyrosine            
(PYY3-36). This PYY3-36 is produced in the gut cells and their 
production is proportional to the kcal intake. This hormone is particularly 
produced after a meal and signals the brain, that the body is no longer 
hungry.  So there should be a balance between the hormones which 
increase and decrease food intake.    
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GENES AND ENVIRONMENT: 
           Our body size depends on the complex interaction between 
environmental factors and genetic background. Only 40% variance in 
body mass is explained by genetic background in humans 45. The major 
reason for a recent trend in obesity is due to alterations in environmental 
factors that increase energy intake and reduced energy expenditure by 
reduced physical activity. Now people are more interested to take 
restaurant foods and greater preference of snack foods, serving sizes are 
larger and also because of sedentary life style physical activity has 
considerably reduced.   
          Persons of genetic background are more prone for weight gain and 
develop obesity related diseases when they are exposed to a modern 
lifestyle during their life time.  
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INFLUENCES OF CHILDHOOD AND PARENTAL OBESITY 
The risk of getting obesity in adulthood also depends on being 
obese as a child or having at least one obese parent. This risk increases 
with increasing age and with degree of childhood obesity.  
MONOGENIC CAUSES OF OBESITY 
After the discovery of leptin, an adipose tissue protein, studies are 
going on to understand the molecular basis of body-fat regulation.  
Leptin gene mutation: 
Leptin is a hormone secreted by adipose tissue. It has 14 amino 
acids. The pathophysiologic relevance of leptin was studied in two 
extremely obese Pakistani cousins. They belonged to a consanguineous 
family. They were found to have a frame shift mutation of leptin coding 
region and premature leptin synthesis termination. Leptin treatment 
successfully reversed the condition. Serum leptin levels increase 
exponentially with fat mass, which shows that in obesity there is 
insensitivity to leptin resulting in body fat deregulation46.     
 Leptin receptor mutation: 
Mutation in leptin receptor gene resulted in hypogonadotropic 
hypogonadism, failure of pubertal development, secondary 
hypothyroidism, and delay in growth. These findings confirm the 
importance of leptin in endocrine regulation of energy balance and 
hypothalamic functions in humans. 
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         Certain other mutations leading to obesity are pro-opiomelanocortin 
gene mutation, melanocortin 4 receptor mutations, prohormone 
convertase 1 gene mutation and mutation of Neurotrophin receptor TrkB.  
POLYGENIC CAUSES OF OBESITY 
Obesity may result from gene –environment interactions or due to 
gene-gene interactions. The major breakthrough given by genome-wide 
association studies was the discovery of fat mass and obesity associated 
gene (FTO). Many studies have shown that a strong association between 
single nucleotide polymorphism in FTO gene and fat mass (BMI) in both 
adult and childhood obesity. This single nucleotide polymorphism in FTO 
gene is strongly associated with type 2 DM47.  
ENERGY METABOLISM 
Total daily energy expenditure (TEE) includes resting energy 
expenditure (REE) (70%), thermic effect of food (10%), energy expended 
during physical activity (20%). REE denotes the energy expended for 
normal organ and cellular function during post absorptive resting state.  
Thermic effect of food (TEF) denotes the energy expended in digestion, 
absorption and activation of sympathetic nervous system after ingestion 
of a meal. Energy expended in physical activity includes energy 
expended during exercise, spontaneous muscle contraction and posture 
maintenance. Certain studies have shown that obese persons usually have 
higher REE than lean persons of same height because obese subjects tend 
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to have a greater lean and adipose tissue cell mass48. In non weight 
bearing activities like cycling, obese persons expend same amount of 
energy as the lean persons. But in weight bearing activities obese persons 
expend more energy than lean ones, as more work is needed to carry their 
increased weight of the body49.  
Other syndromes associated with obesity: 
Cushing, prader willi syndrome, Laurence –Moon- Biedl 
syndrome, Cohen’s syndrome, Carpenter’s syndrome.  
OBESITY AND EVOLUTION 
Are there any evolutionary roots to obesity? 
In the modern obesogenic environment, those who have inherited 
the ancestral energy conserving genes have a genetic risk of developing 
overweight/obesity and associated chronic diseases50. However, this 
phenomenon of thrifty genes as proposed by Neel in 1962 has been 
contradicted by some authors51.  Controversies and contradictions apart, 
obesity seems to have some evolutionary basis that has become a point of 
major concern for modern humans.  
COMMON HEALTH CONSEQUENCES OF OVERWEIGHT AND 
OBESITY 
Increased BMI is one of the major risk factor for noncommunicable 
diseases like: 
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• Cardiovascular diseases mainly stroke and heart disease. This was 
the leading cause of death in 2012 as per WHO report 
• Diabetes 
• Musculoskeletal disorders like osteoarthritis  
• Cancers involving various organs. 
The risk for these diseases increases with increasing BMI. 
Childhood obesity has a higher chance of obesity in adult, disability in 
adulthood and premature death. In addition to these risks, obese children 
will have breathing difficulties, fracture risks, hypertension, and 
psychological effects.  
THEORY OF OBESITY 
There are many theories which describe obesity but none is true for 
everyone. For each one the reason may be different. Researchers have 
shown that obese mice have a deficiency of hormone leptin. The gene 
responsible for hormone leptin is ob gene. It helps to prevent obesity. 
Leptin acts as adipostat by signaling the brain regarding body fat stores. 
When exogenous leptin is administered to leptin deficient rodents, it 
causes decreased food intake, weight loss and increased metabolic 
activity. In some obese persons the level of leptin will be very high which 
shows that they are leptin resistant. This discovery dampens the use of 
leptin in treatment of obesity. Leptin is considered as afferent satiety 
signal.  
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The Driving force for metabolic syndrome: OBESITY 
Obesity is a condition where excessive fat accumulation occurs to 
such an extent that health and well being are affected adversely.  
The prevalence of obesity increases the prevalence of metabolic 
syndrome52. High carbohydrate diets with rich in glycemic index are said 
to worsen metabolic syndrome. Adipose tissue plays a key role in 
metabolic syndrome53. Non esterified fatty acid (NEFA) is the key fuel 
source. In fasting state, adipose tissue triglyceride undergoes lipolysis and 
releases NEFA into circulation. The enzyme involved in lipolysis is 
hormone sensitive lipase. This enzyme activity is enhanced by nor 
epinephrine and suppressed by insulin. During fasting, when the insulin 
level is low, lipolysis is not inhibited and more release of NEFA into 
circulation. Lipids start to accumulate in muscle and liver when NEFA 
supply exceeds the energy needs. All these changes added with metabolic 
alterations leads to metabolic syndrome.  
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METABOLIC SUSCEPTIBILITY: Dysfunctional adipose tissue: 
  Four potential disorders that can accentuate metabolic syndrome 
include genetic forms of insulin resistance, subcutaneous adipose tissue, 
inflammation of adipose tissue and dysfunctional adipose tissue.  
A severe deficiency of adipose tissue is called lipodystrophy54. In 
lipodystrophy fat starts to accumulate ectopically in liver and muscle. It 
results in severe metabolic syndrome.  
Insulin is a major regulator of metabolism of adipose tissue. When there 
is genetic defect in insulin signaling, lipolysis suppression will be 
impaired. Adiponectin release will be reduced55. Adiponectin favors 
insulin sensitivity. Insulin resistant dysfunctional adipose tissue people 
will have high CRP, high leptin levels and increased NEFA, low 
adiponectin –even they are not obese. These persons are prone to 
premature type 2 DM and metabolic syndrome. In obese persons, 
macrophages will invade adipose tissue56. Release of inflammatory 
cytokines will occur when there is activation of these macrophages. The 
cytokines causes insulin resistance.  
MANAGEMENT OF OBESITY 
Energy 
For a sedentary person about 20Kcals per kg of body weight is 
prescribed and about 25Kcals per kg body weight for moderately active 
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person. Food energy intake should not be more than what is necessary for 
expenditure. It should always be lesser than energy consumed.  
The most common methods for reducing obesity are as follows 
1. Dietary control 
2. Exercise 
3. Drug therapy 
Dietary control 
The quantity of food which one is taking should be halved to start 
with. Initially it should be of 100Kcals and it should contain a large 
amount of fibers. Small quantities of food should be taken frequently to 
control appetite and one should eat food slowly than to gulp it down in 
hurry. Diet should contain 1gm of protein per kg of ideal body weight. 
Ghee, butter, eggs, fried foods and fatty preparations, sweets, potatoes 
and alcohol should be avoided. Vegetable oils except coconut and palm 
oil may be consumed to provide the required essential fatty acids. Lightly 
prepared soup like preparations, green vegetables as spinach, bathua, 
cabbage, coriander, spearmint, fenugreek leaves, bottle gourd, ridge 
gourd, or ribbed gourd, salad and fresh fruits should be included in diet. 
Cucumber and or tomatoes should be taken in between the principle 
meals to prevent hunger. Skimmed milk should be taken.  
 Salt intake should be restricted. No extra salt should be added.  
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 Fluid should be taken in abundance as they give feeling of filling 
sensation. A glass of water consumed before a meal lessens the food 
intake.  
 On dieting weight of the body is lost rapidly, say ½ to 2 pounds per 
week for about 6 months. Initially this is due to loss of excess water 
content of the body as evidenced by increased frequency of micturition 
and polyuria. Therefore, the weight is somewhat stationary for a few 
months, when one adopts oneself to new weight and then one starts to 
lose weight again. In this way, when desired weight is reached, one 
should maintain it. 
Exercise: 
Generally, obese persons lead sedentary life style. They have to 
lose their body weight. For this purpose, a low caloric diet with moderate 
exercise as walking for increasing calorie expenditure should be advised. 
 Brisk walking for 30-45 minutes with pleasure daily in the morning 
and evening is to be insisted. Walking at a speed of about 5kilometers per 
hour will involve expenditure of 300Kcals in one hour. Moreover, obese 
persons can also take part in light outdoor games such as badminton, 
table tennis, swimming and cycling etc. This will provide exercise, 
entertainment, close company and at the same time will prevent social 
isolation. For housewives household activities like mopping, sweeping 
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the floor, cleaning the utensils and gardening etc are the forms of 
exercise.  
Drugs 
Laxative- Patient should take husk of isubghol 2-3 teaspoonful 
with milk at bed time or some other laxative containing fibers in 
abundance should be taken. 
Anti-obesity drugs- 
1. Amphetamine sulphate- it is anorexic i.e causes loss of appetite in 
obese patients but is not very effective as its large doses are toxic 
and its prolonged use may cause dependence.  
2. Fenfluramine hydrochloride- It is mostly used in medicine in 
obesity which acts by causing loss of appetite like amphetamine 
but has many side effects like dryness of mouth, palpitation, 
insomnia, depression and hypertension and drug dependence. So it 
should not be given in case of hypertension, heart disease, epilepsy 
and pregnancy.  
3. Phentermine- it is also an anorexic used as a single capsule daily 
4. Diethylproplon hydrochloride- it acts like amphetamines in the 
treatment of obesity. 
5. Orlistat- It is a drug approved by the food and drug authority of 
USA for the treatment of obesity by reducing fat absorption from 
the gastrointestinal tract. 
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Surgical Treatment 
1. Liposuction- Excess of fat from the body is removed but it is 
generally associated with recurrence and a few complications. 
2. Gastric plication- Some surgical staples are placed across the upper 
portion of the stomach due to which the capacity of food intake is 
reduced.  
PANCREAS 
The word pancreas derived from Greek which means all flesh. 
Pancreas has both an exocrine and endocrine part which is a unique 
feature of this organ.  
EMBRYOLOGY 
The endocrine part of pancreas consists of islets and the exocrine 
part is formed by acinar cells. Embryologically, it originates from ventral 
and dorsal regions of foregut endoderm as ventral and dorsal pancreatic 
buds on days 32 and 26 respectively. These buds will fuse at 36 days to 
form pancreas57. The posterior part of head of pancreas develops from 
ventral bud while the remaining part of the organ develops from the 
dorsal bud. By 12th week islets are identified in human embryo. They 
have own independent blood supply. Their function starts by 16th week57. 
There are two types of islets, A cell rich and F cell rich islets. Basically, 
A cell rich develops from dorsal pancreatic bud and F cell rich islet 
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secrete more amount of pancreatic polypeptide develops from ventral 
pancreatic bud58. 
ENDOCRINE PANCREAS 
The endocrine function of the pancreas is performed by variety of 
cells present in the islets of Langerhans. These islet cells were discovered 
by Paul Langerhans, German physician in 1869. These are tight 
aggregation of cells embedded in exocrine tissues of pancreas. Four cell 
types in islets: α cells, β cells, δ cells and PP (pancreatic peptide) cells 
also called γ cells. The β cells constitute major population and secrete 
insulin, the insulin antagonist amylin and some other peptides.  
 Insulin release is stimulated by hormones like glucagon, gastric 
inhibitory peptide, epinephrine, and increased blood glucose and amino 
acid levels. Β cells are polyhedral in shape and secretory granules are 
packed in it. α cells secrete glucagon, δ cells secrete somatostatin and γ 
cells secrete pancreatic polypeptide. In most mammals, β cells lie at the 
centre which is surrounded by a thin layer of α, δ, and PP cells. It is about 
one to three cell thick59. In humans, the concentric segregation of cells is 
less defined with sometimes islets taking the shape of oval and cloverleaf 
pattern. In the islets of mature pancreas β cells constitute 70-80% of islet 
mass. There are about 3, 00,000 -1.5million islets present in the pancreas 
of an adult 70Kg man.   
  
 
 
CELLS OF PANCREAS 
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INSULIN BIOSYNTHESIS 
Insulin was first isolated from pancreatic tissue in 1921 by Banting 
and Best60. In mammals, expression of insulin gene and insulin 
biosynthesis is restricted to the β cells of pancreas61 with possible 
exception of the fetal liver and yolk sac. The main function of β cell is the 
production, storage and regulated secretion of insulin. There is always a 
readily available pool of insulin to meet any sudden increase in glucose 
load. Its release is compensated by insulin biosynthesis. Insulin is a 
peptide hormone. It is synthesized as preprohormone in rough 
endoplasmic reticulum. It is then converted to prohormone. This 
conversion also occurs in rough endoplasmic reticulum by an enzyme 
called signal peptidase.  
This proteolysis arises for the most part cotranslationally, so that 
preproinsulin composition in the β cell is very minimal.  
REGULATION OF INSULIN BIOSYNTHESIS 
The rate of biosynthesis of proinsulin is controlled by factors like 
nutrients, hormones and neurotransmitters. Of the various factors the 
most important is the glucose62. The threshold concentration of glucose 
required to stimulate biosynthesis of insulin is found to be between          
2-4 mM and that required to induce insulin secretion is between 4-6mM63 
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When the blood glucose concentration reaches 10-12 mM, the proinsulin 
biosynthesis attains a maximum concentration. There is a time lag of 20 
minutes between the stimulation of β cell with glucose load and 
significant increase in proinsulin biosynthesis. Its rate is increased to        
10-20 folds by 60minutes. Some other hormones like growth hormone, 
glucagon like peptide-1and glucagon also stimulate insulin biosynthesis. 
The hormones like glucagon and glucagon like peptide stimulate insulin 
biosynthesis via cAMP dependent pathway. The rate of proinsulin 
biosynthesis is increased in obesity64 but there is increase in β cell mass 
and there is islet cell hyperplasia in obesity. Extracellular Ca2+ is needed 
for insulin release due to glucose but proinsulin biosynthesis is 
independent of calcium65. Mg2+ appears to be needed for proinsulin 
biosynthesis but not for insulin release. Long chain fatty acids markedly 
potentiate insulin release. Rough endoplasmic reticulum is the major site 
of proinsulin biosynthesis. The earliest form of secretory granule in the β 
cells is formed in the regions of trans-Golgi. This region is characterized 
by presence of clathrin on their cytosolic surface. It is found that clathrin 
is involved in purging of unwanted proteins from the secretory granules 
during their process of maturation. The conversion of proinsulin to 
insulin and C-peptide occurs in the clathrin coated immature secretory 
granule.  
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NORMAL β CELL FUNCTION: 
The storage and metabolism of cellular fuels is regulated by the 
pancreatic β cell through their insulin secretion. This is done by a 
feedback loop: glycemia causes β cell to secrete insulin; proinsulin 
biosynthesis occurs; then conversion of proinsulin to insulin takes place; 
and the secreted insulin in turn lowers plasma glucose by increasing 
glucose uptake into target cells like skeletal muscle. Insulin secretion 
occurs in pulsatile manner with a periodicity of 11-14minutes. This is 
necessary to fully regulate hepatic glucose production66.  There also 
several large bursts of insulin release occur with meals, which will 
increase the efficiency of nutrient clearance. Oscillatory pattern of insulin 
secretion is called entrainment67. Failure of this entrainment has been 
proved as an early defect in insulin secretion which precedes 
abnormalities in traditional tests. C-peptide is secreted in equimolar ratio 
with insulin but it undergoes minimal hepatic degradation and thus C-
peptide can be used for estimating the true rate of insulin secretion.  
β cell dysfunction in type 2 DM 
The proportion of patients with type 2 diabetes mellitus is 
increasing day by day. WHO predicts that incidence of type2DM will rise 
up to 300 million by the end of 202568. T2DM mostly associated with 
obesity, aging, a high fat diet, inactivity or genetic basis. All these factors 
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will lead to insulin resistance. β cell function is always affected in T2DM. 
Its dysfunction occurs earlier and thus hyperglycemias are predated69. 
There is very little change in insulin resistance during the progression 
from impaired glucose tolerance to DM but there is a substantial change 
in β cell function. β cell failure coincides with progression from IGT to 
overt diabetes70. Even after the onset of diabetes, β cell dysfunction is 
reversible to a great extent by intense glycemic control71. 
SECRETION OF INSULIN IN TYPE 2 DM 
It’s a common finding of obesity pairing with insulin resistance. 
They are found to have hyperinsulinemia but the degree of 
hyperinsulinemia is inappropriately low for the plasma glucose 
concentration. Nevertheless, these patients have sufficient β cell reserve 
to maintain a normal glucose level by dietary restriction with or without 
an oral hypoglycemic drug. It is found that there are defects in β cell 
function of pancreas on the background of insulin resistance which both 
these things converge to form type 2DM. In a study with animal model 
with hyperinsulinemia, obesity, and insulin resistance, before the 
development of diabetes mellitus, inadequate expansion of β cell mass 
was a significant causative factor. Human autopsy findings also support 
this study. These patients have absent first phase insulin and C-peptide 
responses to intravenous glucose, second phase response are also 
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reduced, and glucose-insulin secretion dose-response curve shows a 
marked flattening72. However, this abnormal first phase response persists 
in patients even after strict glycemic control further supporting the 
presence of an intrinsic defect in β cell in patients with type 2 DM. Some 
studies consistently showed that elevated levels of proinsulin in 
association with increases in the molar ratio of proinsulin to insulin; 
which means that β cells of patients with type 2DM release excess of 
immature secretory granules into the circulation. The amount of 
proinsulin secreted in these patients appears to be related to the degree of 
glycemic control and it does not depend on the duration of diabetes. So 
hyperinsulinemia reported in cases with type 2 DM to some extent 
represents hyperproinsulinemia rather than true hyperinsulinemia. In a 24 
hour period, patients with type 2 DM have a higher basal level secretion 
of insulin. Postprandially there is a reduction in the proportion of insulin 
secreted because the amplitude of secretory pulses of insulin is reduced 
rather than the reduction in the number of pulses. Improvements in 
diabetic control will regain β cell secretory activity73. 
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INSULIN SECRETION IN OBESITY 
Resistance to insulin in obesity is characterized by 
hyperinsulinemia. It may be due to a combination of increased production 
of insulin and reduced clearance of insulin. Both the 24-hour insulin 
secretion and basal secretory rates of insulin are 3-4 fold higher in obese 
cases and it strongly correlates with body mass index. At any instance, for 
each level of plasma glucose secretion of insulin rate are much higher in 
insulin resistant subjects, which shows an adaptive response of the β cell 
to peripheral insulin resistance.  In the obese patients, basal secretion of 
insulin provides 50% of the total daily production of insulin and once in 
every 1.5-2 hours secretory pulses of insulin occur74. But however, in 
obese patients, the amplitude of these pulses is greater postprandially. It 
was found, that the increase in insulin secretion in obese patients are due 
to the presence of large functional β cell mass rather than the hyper-
responsiveness to secretory stimuli.  
INSULIN RESISTANCE IN OBESITY 
In obesity, there will be resistance to the effect of insulin in uptake, 
metabolism and storage of glucose. Resistance to insulin is one of the 
major pathogenic problems in type 2 diabetes and is often associated with 
other major pathogenic states like hyperlipidemia, hypertension, 
atherosclerosis and polycystic ovarian disease. A newer concept is that 
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resistance to insulin and hypeinsulinemia may actually contribute to 
development of obesity than being as a cause of obesity. The link is at the 
fat cell level itself. It is proposed that hyperinsulinemia activates an 
enzyme called 11β-hydroxysteroid dehydrogenase in adipose tissue of 
omental site. This will generate active cortisol and promotes cushingoid 
type of fat distribution75. This insulin resistance in obesity and type 2 
diabetes manifests mainly by decrease in insulin stimulated uptake of 
glucose and its metabolism in skeletal muscle and adipocytes and by 
decrease in insulin mediated suppression of hepatic glucose output. This 
is mainly due to down regulation of insulin responsive glucose 
transporter- GLUT4. In both these target organs (skeletal muscle and 
adipose tissue) the resistance to insulin results in reduction of insulin 
binding to its receptor, phosphorylation of its receptor, activation of 
tyrosine kinase and phosphorylation of insulin responsive substrate 
proteins.  
The action of insulin to reduce the blood sugar level is by 
decreasing the hepatic production of glucose and increase in the uptake of 
glucose into fat and muscle. But majority of glucose disposal occurs in 
muscle than to fat. This is because muscle mass is much higher than the 
white adipose tissue mass, muscle provides a major outlet for glucose 
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disposal. Glucose disposal into brown adipose tissue is much higher than 
into muscle in adults. 
  It is also said that VAT is anatomically in contact with portal vein. 
So the liver is exposed to free fatty acid flux and impair glucose-insulin 
homeostasis. This decreases degradation of insulin in liver and decreases 
the utilization of glucose peripherally in obese people and so become 
more at risk for insulin resistance, T2DM and CVD76. 
IMPACT OF BODY FAT LOCATION ON INSULIN REISTANCE 
Many studies have shown that the risk for diabetes and insulin 
resistance rises as body fat content increases from very lean to obese 
implying that dose of body fat has an effect on insulin sensitivity77. 
Although it is seen with measures of general adiposity such as BMI, all 
the sites of adiposity does not contribute to same levels of risk to 
diabetes. Central or intra abdominal fat depots are more commonly 
associated with diabetes and other cardiovascular diseases. This is 
because some biochemical feature of intra-abdominal adipocytes directly 
influences systemic sensitivity of insulin. A leading hypothesis is that 
adipocytes which are located in abdomen are lipolytically more active 
than elsewhere. The increased intraportal FFA levels and flux will hinder 
the clearance of insulin and promote resistance to insulin by mechanisms 
that are still unknown.. It was assumed that reduced clearance of insulin 
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can lead to hyperinsulinemia, this in turn can produce down regulation of 
insulin receptors and desensitizing post receptor signaling pathway. 
Another concept is that intra abdominal adipocytes secrete both 
quantitatively and qualitatively a different combinations of factors which 
lead on to derangement of insulin action systematically.  
LIPOTOXICITY AS CAUSES OF INSULIN RESISTANCE 
The term lipotoxicity has been coined in order to describe the 
negative impact of expanded adipose tissue depot in obesity. It also 
includes lipid accumulation in non adipose tissue. The excess fat 
accumulation in obesity leads to elevated plasma FFA and impaired 
hepatic metabolism. This elevated FFA impairs the ability of insulin to 
decrease the glucose output from liver, and stimulate glucose uptake into 
skeletal muscle and inhibit pancreatic insulin secretion.  
DEFINITION OF DIABETES MELLITUS 
 Diabetes mellitus is a heterogeneous group of metabolic disorder 
characterized by elevated blood glucose and associated with disturbances 
in carbohydrate, fat and protein metabolism resulting from defect in 
secretion of insulin, action of insulin action or both78. 
Criteria for Diagnosing Diabetes Mellitus: 
• Symptoms of DM plus blood glucose taken randomly> 200 mg/dl  
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• Blood glucose taken in fasting > 126 mg/dl 
• 2 hour blood glucose > 200 mg/dl after an oral glucose tolerance 
test. 
Any one of the above criteria can be used for diagnosing DM. 
         Diabetes is called as “STARVATION IN THE MIDST OF 
PLENTY”.  Because the extracellular glucose will be higher whereas 
intracellular glucose is low due to reduced entry of glucose into 
peripheral tissues. Basically diabetes can be classified as Type 1 DM, 
Type 2 DM, gestational DM (Type 3) 
Type 1 DM is mainly due to autoimmune destruction of beta cells of 
islets leading to insulin deficiency. So it is also called insulin dependent 
DM. This mostly occurs before 20 years of age. In Type 2 DM, the major 
defect is insulin resistance and or insulin secretion. Insulin secretary 
defect is usually preceded by insulin resistance which led on to 
exhaustion of beta cells and produces insulin secretary defect. Diabetes 
develops when the insulin secretion becomes inadequate.  
GENETIC CORRELATION IN TYPE 2 DM 
 Type 2 DM strongly correlates with genetic component. The 
concordance rate for the identical twins is 70 to 90%. Similarly if both the 
parents are diabetic the chance for the offspring to be a diabetic is 40%. 
Many genes have been identified in the causation of type 2 DM. 
Currently identified genes are  inward rectifying potassium channel, Zinc 
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transporter, peroxisome proliferators-activated receptor γ(PPAR-γ) and 
the list continues.  
LIPID METABOLISM IN DIABETES 
Obese persons are more prone for diabetes. In a person with insulin 
insufficiency, marked changes in fat metabolism occur. There is 
decreased synthesis of fatty acids and triglycerides and decreased 
conversion of glucose to fats in adipose tissue. Mobilization and 
utilization of fats and fatty acids from fat depots is increased. With 
increased fat catabolism, the production of acetoacetic acid and its 
derivatives acetone, beta-hydroxybutyric acid is increased (ketogenesis). 
In diabetics, glucagon secretion is also increased and this contributes to 
many other metabolic effects.   
BLOOD PRESSURE 
The blood pressure which we usually measure using 
sphygmomanometer gives us useful information about cardiovascular 
status of a man. In the year 1828, mercury sphygmomanometer was 
discovered by Bernoulli.  
It is the product of cardiac output and systemic vascular resistance. 
The cardiac output is increased in obese patients is due to increase in 
blood flow to the adipose tissue. Systemic vascular resistance also 
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increased due to factors like hyperinsulinemia, over activated sympathetic 
nervous system, disordered sleep pattern like sleep apnea. Increase in 
severity of obesity, worsen the blood pressure.  
Systolic pressure: It is defined as the maximum pressure which is 
reached during the cardiac cycle. It indicates the force of contraction of 
heart. Thus it predicts the work done by the heart. 
Diastolic pressure: It is defined as the minimum pressure attained during 
the cardiac cycle. It depends on the total peripheral resistance.  
HYPERTENSION: 
Nowadays, it has become a very common non communicable 
disease. It accounts for more than 85% of excess cardiovascular disease 
risk (CVD). Patients with hypertension are more prone to diabetes than 
those who are normotensives. Hypertension will further increase the risk 
for stroke, retinopathy and coronary heart disease. When both the 
diseases exist together the risk for CVD is doubled. Hypertension 
individuals with diabetes has a characteristic features like isolated 
systolic hypertension, loss of nocturnal dipping of blood pressure and 
pulse, volume expansion, increased salt sensitivity , albuminuria and 
increased tendency for orthostatic hypotension79. As per Framingham 
heart study, rise in systolic blood pressure by 20mm Hg and the risk for 
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cardiac failure increases by 56%. This was proposed by Adler et al80. In 
obese individuals, on the right side of the heart, there is increase in filling 
pressure, pulmonary vascular resistance also increases. Increased 
pulmonary vascular resistance may be due to hypoventilation, left 
ventricular dysfunction or any pulmonary disease. All these pathologies 
are more common in obese people. In obese people with obstructive sleep 
apnea, the condition is even made worse by nocturnal dysrhythmia, right 
heart failure, myocardial infarction, and stroke. Left ventricular diastolic 
dysfunction is more common than systolic dysfunction. When compared 
with normal people, subclinical changes in the structure and function of 
the left side of the heart particularly the left ventricle, such as differences 
in the regional or global strain, were identified in asymptomatic. 
 RELATIONSHIP BETWEEN HYPERTENSION AND DIABETES: 
CVD is the major cause of death in patients with diabetes. It has 
been shown that hypertension leads to insulin resistance and further 
causes hyperinsulinemic state. In patients with essential hypertension, 
fasting and postprandial insulin levels were elevated independent of BMI 
and with a direct positive correlation between blood pressure and plasma 
insulin levels. It is concluded that hypertension is an insulin resistance 
state.  But this association is not for secondary hypertension. It shows that 
there is a common genetic predisposition for diabetes and hypertension.  
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One of the classical features of metabolic syndrome is high blood 
pressure. It has been shown that in one third of hypertensive patients 
metabolic syndrome exists.  
MECHANISM FOR DEVELOPMENT OF HYPERTENSION  
Visceral Obesity 
Visceral obesity plays an important role in development of 
hypertension. Studies show that adipose tissue is a major endocrine organ 
that secretes adipocytokines. When a person develops obesity this 
secretion of adipocytokines get altered which lead to metabolic disorders. 
Accumulated visceral adipose tissue produce and secrete substances like 
IL-6, tumor necrosis factor (TNF)-α, non esterified fatty acids (NEFA), 
angiotensinogen, leptin, visfatin. All these factors lead to development of 
hypertension in metabolic syndrome.  It is said that obesity is a common 
feature of patients with resistant hypertension and >40% patients with 
resistant hypertension are obese. Obesity also reduces the BP lowering 
effect of drugs.  
INSULIN RESISTANCE 
The main pathophysiologic feature of metabolic syndrome is 
insulin resistance. Insulin has an anti-natriuretic effect thereby causing 
renal sodium re-absorption. Even though there is resistance to the actions 
of insulin, the anti-natriuretic effect is preserved and produces 
hypertension in patients with metabolic syndrome. A study by Strazzullo 
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P, et al showed that in individuals with metabolic syndrome proximal 
fractional sodium re-absorption (FPRNa) was much greater than those 
without metabolic syndrome.  Insulin also stimulates endothelin 1 
production. Endothelin -1 act on the vessel wall and increases the blood 
pressure.  
SYMPATHETIC OVERACTIVITY 
In obese individuals serum catecholamines levels and muscle 
sympathetic nervous activity   (MSNA) are found to be elevated. MSNA 
were significantly greater in central obesity individuals. Renin 
angiotensin system is activated thereby producing hypertension in obese 
patients. Insulin resistance raises leptin levels in the plasma and this 
leptin is found to have a property of increasing sympathetic nervous 
activity. So obesity associated hypertension is contributed by leptin 
dependent activation of sympathetic nervous system. 
OXIDATIVE STRESS AND ENDOTHELIAL DYSFUNCTION 
In non diabetic humans, lipid peroxidation which is represented by 
plasma thiobarbituric acid and urinary prostaglandin –F2alpha were 
found to be positively correlated with waist circumference and BMI, 
showing that fat accumulation is correlated with oxidative stress81. 
 Insulin resistance produces impairment in phosphatidyl inositol 3 kinase 
dependent signaling pathway. This causes an imbalance between nitric 
oxide production and endothelin 1 secretion. This imbalance finally leads 
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to endothelial dysfunction.  Many studies have shown that endothelial 
dysfunction is positively correlated with insulin resistance and 
hypertension82. 
ACTIVATED RENIN ANGIOTENSIN SYSTEM 
By affecting function of kidney and by modulating tone of blood 
vessels, blood pressure is crucially regulated by rennin angiotensin 
system. In obese individuals’ expression of certain genes like 
angiotensinogen, angiotensin converting enzyme is more in adipose 
tissue.  
So there is overproduction of angiotensin II in adipose tissue of 
obese patients. Plasma aldosterone level was found to be higher in obese 
patients. It was found that the best predictor of aldosterone levels in 
plasma was abdominal obesity83. 
EFFECT OF OBESITY ON CIRCULATION 
Obesity, by increasing the weight of the body, increases energy 
expenditure during physical activity which also includes moving the 
body. There is also an increase of basal metabolism associated with 
increased mass of adipose tissue. This increased energy requirements of 
the obese will impose a load on the circulatory system and they are not 
able to do the activity with as ease as the non obese persons. But it has 
been said that obese individuals have greater mechanical efficiency than 
normal subjects but there are some studies which opposes this fact. In 
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obesity, the blood volume per kg is reduced, but when calculated with 
regard to the body surface it is normal.  
WEIGHT OF THE HEART IN OBESITY 
Pathologists have found that hearts of obese individuals have 
extensive subepicardial fat depots. Another study also reported the 
presence of fat deposits up to 50% of the heart weight without any sign of 
abnormal heart function. It was said that weight of the heart increases in 
proportion to the body weight. Since hypertension is associated with 
obesity, it is possible that hypertrophy of obese heart may be due to 
hypertension also. In patients with obesity of long duration both 
ventricles are hypertrophied, but the left ventricle is mostly affected. 
DIETARY LIPIDS: 
The major constituents of dietary lipids are chiefly long chain 
triglycerides with lesser amounts of phospholipids, cholesterol, 
cholesterol esters and fat soluble vitamins. The triglycerides contain both 
saturated fatty acids (palmitic and stearic) and unsaturated fatty acids 
(linoleic, linolenic, arachidonic) which are essential fatty acids and 
contain more than one double bond. These lipids are digested almost 
exclusively in the small intestine. Not all of the products of fat digestion 
leave the intestinal epithelium without being altered during transit in the 
epithelial cells. Despite the fact that intraluminal digestion of 
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triglycerides proceeds fairly rapidly to yield appreciable quantities of 
fatty acids, monoglycerides and diglycerides, analysis of lymphatic fat 
shows that most if not all of the fats are in the form of triglycerides. This 
concludes that these products of fat digestion on absorption are 
resynthesised to a large extent back to triglycerides in the cells of the 
intestinal mucosa.  
Free fatty acids with 12 or less carbon atoms after digestion are 
absorbed into portal blood. Fatty acids with 14 or more carbon atoms are 
found to be absorbed through lacteals. Our diet mainly contains fatty 
acids with 16 to 18 carbon atoms. This implies that major route of normal 
intestinal absorption of lipids is through lymphatics.  
LIPOPROTEINS 
 These are molecular complexes consisting of both lipids and 
proteins that provide means for lipid transport between different organs 
and tissues. Lipids by virtue of their immiscibility with aqueous solutions 
depend on protein carriers for transport within bloodstream and 
extracellular fluids.  
STRUCTURE 
These are spherical having a hydrophobic core wrapped in a 
hydrophilic coating. The core is made up of cholesterol esters and 
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triacylglycerols which because of their nonpolar nature always avoid 
contact with water. The hydrophilic surface contains phospholipids, free 
cholesterol and proteins. It interacts with water in the plasma thereby 
promoting solubility of lipoproteins. 
Composition of plasma lipids in adults 
LIPIDS CONCENTRATION (mg/dl) 
TAG 40-140 
Cholesterol 150-200 
Phospholipids 145-250 
Free fatty acids 4-20 
Total 360-680 
ROLE OF MICELLES IN FAT ABSORPTION: 
Micelles are formed by interaction of bile salts with cholesterol. 
They make the lipids soluble and transport them to brush border of 
intestinal mucosal cell. The micelles move down their concentration 
gradient to the mucosal surface. On contact with the surface, the lipid 
portion enters the cell probably by passive diffusion. The bile salts left 
behind diffuse back into the chyme and take up more monoglycerides and 
fatty acids and transport them to brush border. The bile salts thus perform 
a “ferrying function” which is very important for fat absorption.  
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Monoglycerides are hydrolyzed to glycerol and fatty acid during entry 
into the epithelial cells by the lipase present in the cell.  
Long chain fatty acids containing more than 12- 14 carbon atoms 
are resynthesized to triglycerides in the mucosal cells. The resynthesis 
reduces the fatty acid content inside the cell and maintains a favorable 
concentration gradient for the diffusion of fatty acids and monoglcerides. 
The synthesis occurs in the smooth endoplasmic reticulum which 
contains the enzymes and cofactors necessary for the synthesis of 
triglycerides. Free cholesterol formed from cholesterol esters by the 
action of esterases in the lumen and microvilli enter the cell and are re-
established.  
 Most of the short and medium chain fatty acids (12 or less carbon 
atoms) leave the mucosal cell by diffusion into the portal blood. The 
glycerol that is liberated by complete hydrolysis is also absorbed by 
diffusion and some of it travels along with FFA through portal blood. The 
rest of the glycerol is converted to L-glycerophosphate and used in the 
resynthesis of triglycerides and phospholipids in the intestinal epithelial 
cell.  
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APOLIPOPROTEIN 
Protein part of lipoprotein is called apolipoprotein. The most 
characteristic structural feature of apolipoprotein is amphipathic helix, an 
alpha helix in which one side is formed by hydrophobic and the other by 
hydrophilic amino acid side chains.  
NOMENCLATURE OF LIPOPROTEINS 
Many types of lipoprotein exit each having characteristic lipid and 
protein compositions. Their densities are inversely related to their lipid 
content: the higher the lipid content, the lower the density. The various 
classes are               1) Chylomicrons 2) VLDL 3) LDL 4) HDL 
FUNCTIONS OF LIPOPROTEINS 
1. They transport the dietary fat from intestinal mucosa where it is 
absorbed to liver by exogenous lipid transport. It is done by 
chylomicrons 
2. Transfer triacylglycerols (TAG) and cholesterol from liver to other 
tissues by endogenous lipid transport. This is by VLDL and LDL.  
3. Transport cholesterol from extra hepatic tissues to liver by reverse 
cholesterol transport. It is by HDL. 
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LIPOPROETIN METABOLISM 
CHYLOMICRONS 
The dietary TAG is transported by chylomicrons to other tissues. 
As the chylomicrons pass through the capillaries of tissues they bind to 
lipoprotein lipase (LPL). Here TAG is hydrolyzed to FFA and 
monoacylglycerols which diffuse directly into tissues. Chylomicrons also 
deliver dietary cholesterol to liver. 
Synthesis: 
Chylomicrons carry lipids of dietary origin, they are synthesized 
and appear in the circulation only after a meal rich in fats. Their content 
of cholesterol, phospholipids, fat soluble vitamins reflect the lipid 
composition of previous meal.  
METABOLISM  
Initially they contain Apo B48 and Apo A. After entering the 
circulation the nascent particles acquire Apo C II and Apo E from HDL 
and become mature chylomicrons. It becomes functionally competent. 
Apo CII allows the mature particles to activate the enzyme lipoprotein 
lipase (LPL). The activity of LPL is under the influence of various 
hormones like insulin and cortisol84. Insulin causes inhibition of lipolysis, 
peripheral glucose uptake and stimulation of adipocyte differentiation 
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thereby promoting triglyceride storage in adipocytes. Obesity promoting 
effect of cortisol has a synergistic effect with insulin by causing induction 
of LPL in adipose tissue. Other factors which inhibit LPL activity are 
testosterone, growth hormone, tumour necrosis factor (TNF) and 
catecholamine.  
In the peripheral tissues, the activated LPL causes hydrolysis of 80-
90% of chylomicron triacylglycerols. This process causes transfer of A 
and C apolipoproteins to HDL. These changes lead to formation of 
chylomicron remnants, a smaller particle. The fatty acids released from 
hydrolyzed triacylglycerols enter muscle and adipose tissue cells and the 
glycerol part enters the liver where it is used for the synthesis of TAG.  
 
VERY LOW DENSITY LIPOPROTEIN 
SYNTHESIS AND SECRETION: 
Synthesis of nascent VLDL particles occurs in the hepatocytes by a 
series of reactions similar to chylomicrons. It involves assembly of TAG, 
phospholipids, cholesterol and Apo B-100.  
 
 
62 
 
Metabolism 
Mature VLDL is acted upon by LPL in capillaries of peripheral 
tissues. The enzyme is activated by Apo C II of mature VLDL. The 
VLDL, TAG are hydrolyzed more slowly compared to those in 
chylomicrons with residence time in blood of 15-20minutes.  
Progressive stripping of TAG is accompanied by transfer of Apo C 
to HDL.  VLDL remnants possess Apo E which would mediate their 
uptake in liver. The fatty acids released from the degraded TAG are taken 
up mainly by peripheral tissues.  
LOW DENSITY LIPOPROTEINS: 
Most of the LDL is derived from VLDL and IDL but a smaller 
amount is released from the intestine. During its formation from VLDL, 
Apo B100 is the only apolipoprotein retained. Most of the TAG are lost 
during this transition, so that relatively higher concentration of 
cholesterol and cholesterol esters. Apo B100 serves a ligand for LDL 
receptors. 
The major type of lipoprotein involved in the development of 
cardiovascular diseases and also the reason for insulin resistance is small 
dense LDL lipoproteins 85. 
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LDL receptors 
These receptors are present in all cells but are most abundant on 
hepatocytes and adrenal cortex. Helped by Apo B 100 these receptors 
mediate the uptake of cholesterol rich LDL molecules either by liver or 
peripheral tissues especially fibroblast, vascular smooth muscle, 
lymphocytes. It is a highly regulated process of receptor mediated 
endocytosis occurring via clathrin coated pits. LDL receptor is sometimes 
referred to as Apo B100/Apo E receptor because it has high affinity for 
Apo E also and can mediate uptake of IDL particles as well. It is 
important for whole body cholesterol homeostasis. The subsequent 
degradation of LDL in the lysosomal compartment of cells results in the 
release of cholesterol. The free receptor can then return to the surface of 
the cell. It will be used again for uptake of other molecules of LDL.  
HIGH DENSITY LIPOPROTEINS 
HDL particles are called good cholesterol because it acts as 
scavengers by removing free cholesterol particles from extra hepatic 
tissues and are then excreted through bile.  They are produced by 
hepatocytes and intestine or being produced during the process of 
metabolism of other lipoproteins. 
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FUNCTIONS 
It is involved in reverse cholesterol transport.  
It functions as a reservoir of apolipoproteins transferring apo E and apo C 
to nascent chylomicrons and VLDL. 
LDL and Cardiovascular risk 
The initial step in formation of atherosclerosis is arterial intima 
being invaded by plasma LDL. The rate of LDL infiltration depends on 
(1) LDL level in the blood (2) arterial wall permeability86. By some 
process they reach the vascular sub endothelium. A part of LDL gets 
entrapped in extracellular matrix. This entrapped LDL is ripe for 
modification. Some kinds of modifications are fusion of lipoproteins, 
proteolysis, and aggregation. Once this modification has occurred LDL 
has got the capability of potential for inflammation. There will be 
activation of endothelial cells, smooth muscle cells and monocytes/ 
macrophages. In atherogenesis, the key factor is macrophages87 .The 
macrophages undergo apoptosis and releases their excess lipid contents 
into the lipid pool. They also release metalloproteinases which are 
involved in degrading extracellular matrix destruction. All these changes 
produce unstable plaques which are prone to rupture. 
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FAT ACCUMULATION 
In areas where adipose tissue is more labile, namely those areas 
which are depleted by starvation or expanded by hyperphagia and lipid 
accumulation – insulin sensitivity appears most prominent. A study by 
Favarger et al has shown clearly that the primary site of conversion of 
carbohydrate to fat in vivo is the adipose tissue itself88 .The sensitivity of 
adipose tissue to insulin has permitted its use as an assay to determine 
minute amounts of insulin which is biologically active89. 
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MATERIALS AND METHODS 
STUDY DESIGN: This was a cross-sectional type of study.    
STUDY CENTRE AND PERIOD: This study was carried out in 
Tirunelveli Medical College Hospital from August 2016 to June 2017 
SAMPLE SIZE: The sample size was 100  
STUDY GROUP:  The study group was divided into cases and controls 
based on their WC and BMI values. If both the values were normal they 
were considered as controls. The remaining subjects with either increased 
WC or with increased BMI or both were taken as cases. Their parameters 
were analysed. 
ETHICAL CONSIDERATIONS:  
Institutional ethical committee clearance was obtained prior to the 
commencement of the study. The patients who were attending the non-
communicable disease OPD were recruited for this study. All the subjects 
were clearly explained about the study in their own language. Informed 
consent was obtained from those who were willing to participate in this 
study. 
INCLUSION CRITERIA: 
 Female patients 
 Age group of 20-45 years 
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EXCLUSION CRITERIA: 
 Known diabetic and hypertensive patients 
 Cardiovascular disorders,  
 Thyroid disorders and  
 History of Chronic steroid therapy 
 Menopausal women  
METHODOLOGY: 
After getting informed consent, the information about past history, 
menstrual history was noted in a separate proforma sheet. Then General 
and systemic examination was done. Their anthropometric measurements 
like height, weight and WC were taken.  
Measurement of Height: 
With participants in bare feet, using a non stretchable measuring 
tape which was secured to the wall, height was measured in centimetres 
to the top of the head     (nearest 0.5cm) 
Measurement of weight: Using a professional body weight scale, weight 
was measured in kilograms, with only light clothing and after asking 
them to empty all belongings.  
 
  
MEASUREMENT OF HEIGHT 
 
 MEASUREMENT OF WEIGHT 
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Measurement of BMI: 
BMI was calculated using Quetlet’s formula: weight (kg)/ height (m2).  
Measurement of Waist Circumference: 
According to WHO STEPS protocol for measuring waist circumference, 
it is advisable to make measurement at the level of midpoint between 
lower margin of last palpable rib and top of iliac crest at the end of 
normal expiration. Because at this point the lungs are at their functional 
residual capacity and it was measured in centimetres90.  
By WC, the value more than 80cm were defined as obese and those with 
WC<80cm were said to be normal. The accuracy of these measurements 
depends on the correct positioning; the tape should be kept parallel to the 
floor at the level of measurement and the tightness of the measuring tape. 
The WHO STEPS protocol states that both for measurement of HC and 
WC, the tape should be snug around the body but it should not be kept so 
tight to cause constriction.  It also recommends the use of a stretch 
resistant tape that provides a constant 100g tension90. 
BMI(kg/m2) Classification 
18.5-22.9 Normal 
23.0-24.9 Overweight 
>25 Obese 
 MEASURING WAIST CIRCUMFERENCE 
 
 
69 
 
Measurement of Blood pressure: 
Blood pressure was determined using standard mercury 
sphygmomanometer after 5 minutes of rest. BP >140/90 mm Hg were 
considered as hypertensive.  
BLOOD INVESTIGATIONS 
After an overnight fasting, under strict aseptic precautions, blood samples 
were collected from antecubital vein using 5ml disposable syringes.  
Fasting blood sugar was estimated using EM360 Fully automated 
biochemical analyzer (LIQUIXX- Trinder’s method) 
Lipid profile was estimated using ACCUCARE CHOLESTEROL-SLR 
(Enzymatic colorimetric method) 
Results were interpreted as 91 
PARAMETERS NORMALVALUES(mg/dl) ABNORMAL(mg/dl) 
FBS <126 >126 
Triglyceride <150 >150 
T.Cholesterol <200 >200 
LDL <130 >130 
HDL >50 <50 
 
  
MEASURING BLOOD PRESSURE 
  
TAKING BLOOD SAMPLE 
 
  
 
 
EM 360 FULLY AUTOMATED BIOCHEMICAL ANALYSER 
 
 
 
STATISTICAL 
ANALYSIS 
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STATISTICAL ANALYSIS 
Databases like height, weight, BMI, WC and the laboratory 
parameters like FBS, Total Cholesterol, HDL,TGL,LDL and the blood 
pressure values were entered in Microsoft Excel sheet and a master chart 
was prepared. Statistical analysis was done by SPSS software version 
20.0. 
 Unpaired ‘T’ test was used to compare the mean, standard 
deviation between the groups created. ‘p’ value less than 0.05 was taken 
as statistically significant. Pearson Correlation was used to evaluate the 
correlation coefficient. 
 
INCIDENCE OF OBESITY AMONG THE SAMPLE 
POPULATION BASED ON WAIST CIRCUMFERENCE 
 
 
Obesity
68%
Normal
32%
INCIDENCE OF OBESITY BASED ON 
WC
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INCIDENCE OF OVERWEIGHT AND OBESITY AMONG 
SAMPLE POPULATION BASED ON BMI 
 
 
DISTRIBUTION OF WC AND BMI AMONG SAMPLE 
POPULATION 
 
 
 
Normal
70%
Overweight
14%
Obese
16%
OBESITY INCIDENCE BASED ON BMI
Inc BMI WC 
Normal, 11
BMI and WC 
Normal, 21
BMI Normal WC 
Inc, 49
Both BMI and 
WC 
Increased,   19
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MEAN WC OF THE SAMPLE POPULATION 
 
 
 MEAN BMI OF THE SAMPLE POPULATION 
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TABLE 1: ASSOCIATION BETWEEN WC AND FBS 
GROUP FBS p Value 
 
 
WC- Normal 
 
MEAN SD  
 
               <0.0001* 
98.81 
 
22.20 
 
WC- 
Increased 
 
124.97 
 
22.02 
*Highly significant 
  Highly significant association between WC and FBS. 
  FBS is significantly increased in WC increased group.  
 
 
*Highly Significant  
 MEAN FBS  
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 Pearson Correlation ‘p’value  
WC 0.754 0.0001* 
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SCATTER DIAGRAM 
 
 
WC is positively correlated with FBS 
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TABLE 2: ASSOCIATION BETWEEN WC AND TOTAL 
CHOLESTEROL 
GROUP TOTAL 
CHOLESTEROL 
p Value 
 
 
WC- Normal 
MEAN SD  
 
               <0.0001* 
182.57 
 
41.91 
 
WC- Increased 
 
231.36 
 
41.71 
*Highly significant 
 Highly significant association between WC and Total Cholesterol. 
 Total Cholesterol is elevated in WC increased group. 
 
                  *Highly Significant  
MEAN TOTAL CHOLESTEROL 
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TABLE 3: ASSOCIATION BETWEEN WC AND TGL 
 
GROUP TGL p Value 
 
 
WC- Normal 
 
MEAN SD  
 
               <0.0001* 
138.68 
 
     21.26 
 
WC- Increased  
163.05 
 
21.22 
*Highly significant 
 Highly significant association between WC and TGL. 
 TGL level is significantly elevated in WC increased group. 
  
     *Highly Significant  
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 Pearson Correlation ‘p’value  
WC 0.674 0.0001* 
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Table 4: ASSOCIATION BETWEEN WC AND HDL 
 
GROUP HDL p Value 
 
 
WC- Normal 
 
MEAN SD  
 
               0.0059* 
51.12 
 
7.19 
 
WC- Increased 46.82 7.09 
*Highly significant 
 Highly significant association between WC and HDL. 
 HDL level is significantly lowered in WC increased group. 
 
*Highly Significant  
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 Pearson Correlation ‘p’value  
WC -0.696 0.0001* 
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TABLE 5: ASSOCIATION BETWEEN WC AND LDL 
 
GROUP LDL p Value 
 
 
WC- Normal 
 
MEAN SD  
 
               <0.0001* 
103.87 
 
    46.10 
 
WC- Increased  
158.47 
 
45.475 
*Highly significant 
 Highly significant association between WC and LDL. 
 LDL level is significantly elevated in WC increased group. 
 
 
*Highly Significant  
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TABLE 6: ASSOCIATION BETWEEN WC AND SYSTOLIC BP 
 
GROUP SYSTOLIC BP p Value 
 
 
WC- Normal 
 
MEAN SD  
 
               0.0002* 
120.37 
 
15.88 
 
WC- Increased  
133.82 
 
16 
*Highly significant 
 Highly significant association between WC and Systolic Blood 
pressure. 
 Systolic BP is significantly elevated in WC increased group. 
 
 
*Highly Significant  
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Table 7: ASSOCIATION BETWEEN WC AND DIASTOLIC BP 
 
GROUP DIASTOLIC BP p Value 
 
 
WC- Normal 
 
MEAN SD  
 
               0.0001* 
75 8.63 
WC- Increased  
82.52 
8.66 
*Highly significant 
 Highly significant association between WC and diastolic blood 
pressure. 
 Diastolic BP is significantly elevated in WC increased group. 
 
*Highly Significant  
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TABLE 8: ASSOCIATION BETWEEN BMI AND FBS 
 
GROUP FBS p Value 
 
 
BMI- Normal 
 
MEAN SD  
 
               0.84 
116.31 21.87 
BMI- Increased 117.26 22.00 
 
 p value is not statistically significant. 
 BMI is not significantly associated with FBS. 
         p value is not statistically significant 
 
TABLE 9: ASSOCIATION BETWEEN BMI AND 
T.Cholesterol, TGL 
 
GROUP T.CHOLESTEROL p Value TGL p value 
 
 
BMI- 
Normal 
 
MEAN SD  
 
 0.052 
 
MEAN 
SD 
 
 
 
0.136 210 41.78 153 21.18 
BMI- 
Increased 
227.9 41.92 159.96 21.31 
 p value is not statistically significant. 
 BMI is not significantly associated with T.cholesterol and TGL. 
 
 Pearson Correlation ‘p’value  
BMI 0.231 0.21 
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BMI Pearson Correlation ‘p’ value 
T.Cholesterol 0.302 0.002* 
TGL 0.313 0.002* 
*Significant 
 
TABLE 10: ASSOCIATION BETWEEN BMI AND HDL 
GROUP HDL p Value LDL p value 
 
 
BMI- 
Normal 
 
MEAN SD                 
 
 
0.0001* 
 
MEAN 
SD 
 
               
0.056 
50.7 7.12 135 45.61 
BMI- 
Increased 
42.36 7.10 154.23 45.58 
*p value is highly significant 
 There is highly significant association between BMI and HDL. 
 HDL level is significantly lowered in BMI increased group. 
 BMI is not significantly associated with LDL. 
 
*Significant  
 
 
 
 
 
BMI Pearson Correlation ‘p’value  
HDL -0.312 0.002* 
LDL 0.309 0.002* 
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TABLE 11: ASSOCIATION BETWEEN BMI AND BP 
 
GROUP SYSTOLIC BP p Value DIASTOLIC BP p value 
 
 
BMI- 
Normal 
 
MEAN SD  
 
 
0.73 
 
MEAN 
SD 
 
                
 
 
0.032* 
129.17 15.79 79.37 8.65 
BMI- 
Increased 
130.33 15.76 83.46 8.65 
*significant 
 *p value was statistically significant. 
 BMI is significantly associated with diastolic BP. 
 
 
 
 
 
 
 
 
 
BMI Pearson 
Correlation 
‘p’value 
Syst. BP 0.085 0.401 
Diast.BP 0.017 0.868 
  
 
 
    
 
 
 
 
 
 
 
DISCUSSION   
84 
 
 
   Among the 100 people taken as sample, 68% of women were 
said to be obese based on WC as their WC value was more than 80 
cm. The remaining 32% were said to be normal as their WC was 
less than 80 cm. Recent data from National Family Health Survey 
-4 said that obesity among women is rising very fast. At present 
23.6% of Indian women are obese. In the year 2005-2006 this rate 
was 12.6 %. 
             Similarly, among the same sample population, 70% were 
normal as their BMI was less than 23. 14% were overweight as their 
BMI was between 23 and 24.99. The remaining 16% were obese as 
their BMI was more than 25. WHO criteria for Asian population 
was used to categorize sample population92. According to Obesity 
update 2017, women of rural areas who were less educated were 
two to three times more likely to be overweight and obese than 
educated people.  
  From our study, it was found that when WC was utilized as an 
index for obesity more number of people was classified under the 
category of obesity and so medical care will be extended to more 
number of people. This was supported by a study by Dalton et al93. 
The study was carried among Australian adult population. He found 
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that based on BMI 20.8% of adults were classified as obese but with 
WC 30.5% were brought under obese category. 
 In our study it was observed that 49% of the people had normal 
BMI but increased WC; 21% of the people had both normal BMI 
and normal WC; 19% of the sample population had both increased 
BMI and WC; the remaining 11% had increased BMI with normal 
WC. This revealed that greater number of people in the sample 
population had a normal BMI but with increased WC. 
  The mean WC among the Group I (WC normal group) was 75.56 
and the mean WC among Group II (WC increased group) was 
89.85. 
 Misra and Vikram et al94, performed a study in India to detect the 
validity of WC cut off values which was proposed internationally and to 
create action levels for Asian Indians. They declared that women with 
WC > 72 cm should be considered at action level 1. This means they 
should be advised to lose weight or avoid increase in weight. Women 
with WC > 80 cm are at the level of action 2. For them medical 
management of weight reduction be instituted. In our study, most of the 
population exceeds action 2. It's a great threat to the society. So we 
should initiate an action.  
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 From our study, the mean BMI among the normal people (BMI 18-
22.9) was 21.69. The mean BMI of the people who were overweight 
(BMI 23-24.99) was 23.72. The mean BMI of the obese people 
(BMI > 25) was  29.74 
 In our study, there was a highly statistically significant association 
found between WC and FBS (‘p’ value <0.0001). Also a highly 
significant positive correlation between FBS and WC was 
seen(r<1). The mean FBS of WC normal group was 98.81 and for 
the WC increased group was 124.97. It was also found that no 
statistically significant association exist between FBS and BMI (p 
<0.84). 
This was supported by Ren-Nan Feng et al95. They analyzed data 
from 5 different districts of northern china which included 8940 residents. 
Anthropometric measurements and laboratory values were analyzed. 
They depicted that visceral fat is the main source of inflammatory 
cytokines and free fatty acids. This will lead on to insulin resistance and 
dyslipidemia. Thus WC was more strongly associated with diabetes 
mellitus than BMI.  
A study by Hans Wahrenberg et al96 showed that waist 
circumference is a strong independent risk factor for insulin resistance. It 
is strong enough to replace BMI, WHR and other measures of total body 
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fat stores to predict the occurrence of insulin resistance. It’s a simple tool 
to exclude insulin resistance. 
Insulin is a major regulator of metabolism of adipose tissue. 
According to Abate N et al , when there is genetic defect in insulin 
signaling, lipolysis suppression will be impaired. Release of adiponectin 
will be reduced . Adiponectin favors insulin sensitivity. These persons are 
prone to type 2 DM and metabolic syndrome. In obese persons, 
macrophages will invade adipose tissue. Release of inflammatory 
cytokines will occur when there is activation of these macrophages. 
These cytokines causes insulin resistance.  
Silke Feller et al97, did a prospective study in Europe where they 
investigated the association between nutrition, lifestyle and chronic 
diseases, 15,491 women were involved in the study. They followed them 
for 8 years, among the participants 425 women developed type 2 DM. 
They showed that to estimate the diabetic risk, both BMI and WC should 
be assessed but WC was more important for predicting the diabetic risk 
particularly in low or normal BMI individuals. 
Another study by Rangtao et al98. In this study it was found that 
waistline in Chinese females was highly associated with T2DM. This is 
because visceral fat is also an endocrine organ which secretes hormones 
and cytokines whereas non visceral fat will not do. These secretions are 
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the major factors leading to the development of DM in people with 
increased WC. It correlated well with another study by Tatiana Y. 
Warren et al99.  They conducted the study among 834 African American 
Women. They showed that a significant and independent association 
exists between WC and FBS. 
According to a study by Yoon KH et al, Asian ethnicity people are 
more prone to get diabetes even at lower levels of obesity and younger 
ages and thus have the tendency to develop diabetic complications much 
earlier. 
Ian Janssen100 conducted a study, where 14924 participants were 
involved. They were grouped into categories of BMI and WC according 
to National Institutes of Health cut offs. It was found that women who 
were with low or normal weight but had a large weight circumference had 
a 2.74 fold increased risk for cardiovascular events. 
 Similarly, when compared between the groups, more incidence of 
dyslipidemia was seen among the group where WC was increased.  
The mean Total cholesterol of the WC normal group was 182.57 
whereas it was 231.36 in the other group.  There was a highly 
statistically significant association (p<0.0001) and also a significant 
positive correlation(r<1) between WC and Total cholesterol. Thus 
WC increases the risk of dyslipidemia. Also in our study, BMI also 
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positively correlated with Total cholesterol. But more positive 
correlation was between Total cholesterol and WC. 
This finding was supported by a study conducted among overweight 
and obese adolescents. It was done by Grober Gratz et al101 . They 
showed that WC was highly correlated with dyslipidemia.      
WC is as such is a risk factor for abnormal lipid profiles.  Also 
increased blood sugar levels can itself alter lipid profile values.  This was 
in accordance with the study by Pietzsch J et al102. They found that 
persons with impaired glucose tolerance and T2DM have increased 
catabolism of HDL, producing a low HDL value and all other lipid 
parameters were elevated. The reason for this finding may be decrease in 
the lipoprotein lipase activity which will impair the HDL particles 
maturation. Normally insulin leads to stimulation of lipoprotein lipase. In 
case of insulin resistance, this action is blunted. 
It is a well known fact that increases in cholesterol has a greater risk 
for CVD. From the study by Higgins et al103, mortality rate predicted by 
waist circumference was higher than other types of anthropometric 
measurements. 
 In our study, the mean TGL value of WC increased and normal 
group were found to be 163.05 and 138.68 respectively. TGL level 
was significantly elevated in WC increased group. TGL also 
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showed positive correlation with BMI but was more positively 
correlated with WC than with BMI. It was found that when the WC 
increases, HDL decreases and TGL and LDL increase.  
This finding goes hand in hand with a Brazilian study by Cercato et 
al104, which was done in Sao Paulo. They assessed 1213 adults from that 
Brazilian population which showed that the main altered lipid profile 
found in central obesity was increase in TGL and or decrease in HDL 
levels. Studies by Menke A et al105, Zhu S et al106 reported that 
abdominal adiposity in adults had a stronger and consistent positive 
correlation with TGL and TC: HDL ratio than with general adiposity.    
There was a little modification in the result of Hu et al107.  His study was 
done in American Indians and concluded that obesity leads to decrease in 
HDL levels and increase in TGL levels but central obesity were more 
frequently associated with not much altered lipid profile.  
Another kind of thought explained by Hunter et al108 and Zamboni et 
al109.  In the study by Zamboni et al increase in visceral adipose tissue 
produces increase in serum TAG level which was independent of HDL 
level. According to Hunter et al, increase in central obesity increases 
TAG level in post menopausal women with not much alteration of HDL 
level. 
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According to Tarek Faour et al110, in central obesity, brown adipose 
tissue which is metabolically more active will be present around the 
abdomen whereas in peripheral obesity, less metabolically active white 
adipose tissue exists. The brown adipocytes within the abdomen will 
break down into its product of TGL and free fatty acids and they also 
release TNF and Leptin. These are the inflammatory markers. This will 
drain into the liver through portal system. They also tend to reduce the 
sensitivity of peripheral tissues to insulin. 
It was found that subcutaneous fat cannot store more amount of energy. 
So excess energy will over flow to intra abdominal adipose tissue (IAAT) 
and also to skeletal muscles and liver. This causes metabolic dysfunction 
of the organs like insulin resistance in liver and muscles. So, we can say 
that the index for fatty acids overflow is IAAT. 
According to Ravi GR et al111, there was a direct correlation between 
plasma TGL level and insulin resistance. This is because TGL may 
influence an early pathway of insulin action. This relation is applied vice 
versa also.  
 The mean HDL level in WC increased and normal group were 
46.82 and 51.12. Both BMI and WC were negatively correlated 
with HDL. This means HDL level decrease with increase in WC 
and BMI.  But HDL was more negatively correlated with WC.  
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Study by Tarek Faour et al110 gives the reason behind the low level of 
HDL level in central obesity. The metabolically active abdominal adipose 
tissue on its break down produce free fatty acids and TGL. These 
products will reach the liver due to increase in hepatic uptake and they 
will be converted again to TGL. Thus there is an increase in the level of 
TGL which will stimulate the production of VLDL and Apo B. Now a 
situation develops with raised VLDL level and normal amount of 
Cholesterylester transfer protein (CETP). This will activate the exchange 
between TGL of HDL and VLDL. This produces HDL molecule with 
more of TGL and VLDL with more of cholesterylesters.  So remnants of 
VLDL rich in cholesterol predispose to atherosclerosis and HDL with 
TGL will be subjected to hydrolysis in the liver by the enzyme liver 
lipase. HDL will get separated from the surfactant protein and thus can be 
easily filtered in the kidney. Thus producing a decrease in HDL level in 
obesity.  
This was also supported by Nevin Sanlier et al112. They did the 
study to determine the association between lipids, homocysteine levels 
and obesity. They found that there was a negative correlation between 
BMI and HDL cholesterol and positively correlated with homocysteine 
levels. This finding was also evidenced by Angelo Pietrobell et al113.   
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 The mean LDL level in WC normal and increased groups was 
103.87 and 158.47 respectively. It showed a highly significant 
association with WC. LDL was more positively correlated with 
WC than with BMI. LDL level was significantly elevated in WC 
increased group.  
Widely accepted reason for CVD is dyslipidemia. According to 
Nambi et al114, high level of blood glucose in obesity can influence LDL 
in plasma. In the presence of high blood glucose, more LDL will get 
glycosylated. This glycated LDL has more affinity for LDL receptors 
present over macrophages. This promotes foam cell formation, 
proliferation of smooth muscle cells and toxicity to endothelium.  
The overproduction of VLDL from the liver accompanying obesity 
is the crucial factor for insulin resistant and hyperinsulinemia. LDL 
clearance is mediated by apo B/E receptor, also called LDL receptor.  
LDL particles are more prone to be getting modified like glycated and 
oxidised. They have a smaller diameter and so they can get located in the 
sub endothelial space from where leukocyte ingestion, inflammation and 
plaque transformation occur115. These modified LDL lead to reduced 
clearance by its receptor and produces elevated LDL level in obese 
individuals116. 
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According to National Cholesterol Education Project, lowering 
of LDL level in moderate and high risk cases can lead to decrease in their 
mortality due to cardiovascular events. 
The initial step in formation of atherosclerosis is arterial intima being 
invaded by plasma LDL. They reach the vascular sub endothelium. A part 
of LDL gets entrapped in extracellular matrix. This entrapped LDL is ripe 
for modification. Some kinds of modifications like fusion of lipoproteins, 
proteolysis, and aggregation will occur. Once it occurred LDL has got the 
capability of potential for inflammation. There will be activation of 
endothelial cells, smooth muscle cells and monocytes / macrophages. In 
atherogenesis, the key factor is macrophages. The macrophages undergo 
apoptosis and release their excess lipid contents into the lipid pool. They 
also release metalloproteinases which are involved in degrading 
extracellular matrix destruction. All these changes produce unstable 
plaques which are prone to rupture. 
 In our study, the mean systolic and diastolic BP of waist 
circumference increased group was 133.82 and 82.52 mm Hg 
respectively (‘p’value < 0.0001). Both were highly significantly 
associated with WC. BMI also showed a weak association with 
diastolic BP. 
95 
 
  This finding was supported by a study conducted in Chinese 
population where they followed up 10,000 Chinese people including both 
males and females for six years concluded that rate of abdominal obesity 
was increased upto 62% among females and it was increased upto 30% 
among men. One in 5 had developed hypertension. The people who 
gained weight around their belly had significant risk for high blood 
pressure117.  
    This was also supported by Reilly et al118. Excess abdominal fat 
directly causes overstimulation of Renin- Angiotensin- Aldosterone 
system. It also acts indirectly through hyperinsulinemia to produce 
hypertension. 
     Siani A, Cappuccio et al119 conducted a study called Olivetti Heart 
study. Total of 1079 members participated in this follow up study. The 
results of this study showed that central adiposity leads to hypertension 
irrespective of insulin resistance and body mass index. It was against the 
finding by Ren-Nan Feng et al. This study among northern Chinese 
population indicated that BMI had a strong association with hypertension 
whereas WC with T2DM.  
     Kaushik Bose et al120 did a study on Bengalee male jute mill workers 
of Belur, West Bengal. The aim of this study was to correlate waist 
circumference on blood pressure. They found that centrally obese people 
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had a greater systolic BP, diastolic BP and mean arterial pressure than 
centrally non obese individuals. This finding was irrespective of age and 
BMI. Gerber et al121 also proved the same. 
 BMI assess the general weight of an individual. As the weight 
increases, BMI increases. This will increase the peripheral 
resistance and body fluid volume. Increase in peripheral resistance 
is because of activation of renin angiotensin system producing 
functional constriction of peripheral vessels, alteration of cellular 
membranes and structural hypertrophy122. 
 Finally, from our study it was found that WC was more positively 
correlated with FBS, lipid profile and blood pressure than BMI.  
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SUMMARY AND CONCLUSION 
 Obesity is a rapidly developing health problem of the society. 
There are few studies are available to bring out the obesity related 
health risks in South Tamilnadu, particularly in Tirunelveli district 
this study was being done. It affects both the urban and rural. 
  This study was done in Tirunelveli Medical College hospital. It 
was a cross sectional study. Sample size was 100. Anthropometric 
measures were taken and blood samples and blood pressure were 
analysed. 
 With the rising prevalence of obesity and its associated 
comorbidities, we have to take an action to prevent and manage 
this dyslipidemic state to keep the cardiovascular risks under 
control. 
 From our study, it was found that when WC was used as a measure 
of obesity, more number of people was brought under obese 
category. So we can extend our health care system and more 
number of people will be advised about health maintenance. This 
will create a chance to lower the incidence of cardiovascular risks 
of the public.  
 Since WC had a stronger association with fasting blood sugar, lipid 
profile and blood pressure than BMI, this simple measurement 
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using measuring tape can predict the risk of an individual. It is a 
simple, cost effective, non invasive method which can be 
considered in routine clinical practice. 
 
 Public should be advised to maintain a low and stable WC. 
 
“OUR WAISTLINE IS OUR LIFELINE” 
 
 
FUTURE SCOPE 
 In future, this study can be extended among large number of 
people including both males and females to detect the BEST of 
anthropometric measure. 
 Biochemical markers like lipoprotein lipase, homocysteine can be 
included to improve the efficacy of WC. 
 To get more information 2hr postprandial blood sugar has to be 
evaluated. 
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ANNEXURES 
 
 
 
 
 
 
 
  
 
 
  
 
 
PROFORMA 
Op No:        DATE: 
NAME:          
  
AGE:         
SEX: 
ADDRESS: 
 
EDUCATION/OCCUPATION: 
PAST HISTORY: 
H/O diabetes:    Yes/No 
H/O hypertension:       Yes/No 
H/O Cardio vascular disease:  Yes/No 
H/O Chronic steroid therapy: Yes/No 
H/O thyroid disorder:   Yes/No 
MENSTRUAL HISTORY: 
A) Attained menopause: Yes/No 
Other Medications:  
GENERAL EXAMINATION 
Anaemia  
 Icterus 
Pedal oedema 
Vitals: 
Pulse:    Temp:   Respiratory rate: 
Blood pressure ..................in mm Hg  
Anthropometric Measurements  
Height:      Cm 
Weight:   Kg    
Body Mass Index:                         Kg/m2 
Waist circumference: i             Cm 
Systemic examination: 
Respiratory system 
Cardiovascular system 
Central nervous system 
Any other details of illness: 
Blood investigations: 
Fasting blood sugar:      
Lipid profile: 
 A) Total cholesterol   B) HDL 
 C) LDL:     D) TGL: 
CONSENT: I hereby give my volunteer consent for the above study. 
                                    
Signature 
  
 
 
MASTER CHART 
 
 
 
 
 
 
 
 
S.NO Name Age Sex Ht(cm) wt(Kg) BMI WC(cm) FBS(mg/dl) T.Chol(mg/dl) TGL(mg/dl) HDL(mg/dl) LDL(mg/dl) Sys.BP(mmHg) Dias.Bp(mmHg) 
1 Jeyalakshmi 39 F 168 65 23 95 150 250 180 45 169 140 90 
2 Durachi 35 F 169 60 21 95 140 270 180 45 189 140 90 
3 Seethalakshmi 30 F 144 45 21.7 85 90 170 130 55 89 150 80 
4 Subbhu 45 F 165 61 22.4 92 135 245 170 54 176 140 86 
5 petchiyammal 40 F 150 45 20 78 95 150 125 55 70 100 70 
6 sorna 39 F 170 66 22.83 94 140 216 145 50 152 140 80 
7 lilly 39 F 148 48 21.9 68 96 154 134 50 77 110 80 
8 prema 35 F 167 63 22.58 91 138 260 175 35 190 140 90 
9 Kavitha 40 F 177 68 22 78 128 170 130 53 91 120 80 
10 Amutha  39 F 165 59 21.7 93 150 267 185 50 195 140 90 
11 Thangam 32 F 148 43 20 80 95 150 125 55 70 100 70 
12 Nangai 39 F 164 61 22.6 90 130 245 180 45 164 140 90 
13 Selvam 35 F 168 57 20.2 90 142 260 175 55 190 140 90 
14 pushpam 35 F 165 59 21.7 95 140 256 185 55 189 150 80 
15 thilagavathi 31 F 150 50 22.2 80 99 210 152 50 130 110 70 
16 fathima 40 F 156 66 27 79 130 180 130 35 104 140 80 
17 Kamala 39 F 168 57 20.2 92 156 245 165 50 173 144 90 
18 Daisy  35 F 145 44 22 80 99 170 130 53 91 120 80 
19 Alageswari 37 F 169 64 22.4 90 152 260 170 51 191 140 80 
20 fathima 40 F 169 65 22.7 89 139 250 185 40 173 140 70 
21 Shanthi 35 F 162 60 22.8 90 148 265 180 48 194 110 80 
22 leelavathi 40 F 165 70 25.7 88 149 240 175 40 165 134 90 
23 lalitha 38 F 168 61 22 91 150 255 185 40 178 140 90 
24 sankarammal 37 F 148 48 21.9 68 130 158 129 56 76 100 70 
25 varalakshmi 36 F 145 50 23.8 79 130 210 150 50 130 110 90 
26 Kamatchi 32 F 168 59 20.9 94 155 230 185 55 159 150 90 
27 Esther 38 F 144 45 21.73 74 91 158 129 56 76 120 80 
28 Bhramachi 31 F 148 38 18 79 85 160 137 58 74 110 70 
29 samuthra 40 F 139 45 23 89 132 235 150 42 163 110 94 
30 Gomathi 33 F 154 59 24.89 78 115 220 160 47 141 138 80 
31 uma 30 F 151 53 23.24 80 90 230 165 43 154 110 84 
32 mariyammal 38 F 140 43 21.93 79 91 158 129 56 76 120 80 
33 srirengam 34 F 165 57 20.9 90 100 231 143 55 170 150 90 
34 latha 38 F 153 49 20.94 74 89 142 125 60 57 110 70 
35 vanitha 40 F 159 65 25.7 102 155 332 165 40 259 140 90 
36 barakath 32 F 153 46 19.65 74 90 145 137 52 65 120 80 
37 backiyam 35 F 158 55 22 77 95 190 145 51 110 110 70 
38 Deivanai 39 F 152 52 22.51 76 115 150 130 54 70 110 70 
39 senthilkumari 35 F 155 55 22.8 89 140 154 145 50 75 144 80 
40 Arumugam 40 F 152 50 21.6 90 105 230 165 43 154 140 70 
41 Paramasakthi 32 F 141 45 22.72 74 92 164 128 54 85 120 80 
42 Mahalakshmi 36 F 152 53 22.94 80 125 150 130 54 70 110 70 
43 saraswathi 40 F 155 53 22.08 75 92 220 160 47 141 120 80 
44 umaselvi 39 F 156 54 22.1 88 105 255 180 50 189 140 80 
45 Thangamani 38 F 158 55 22.03 90 112 265 180 51 194 150 90 
46 Geetha 32 F 153 50 21.3 92 130 250 140 50 193 140 90 
47 Ushanandhini 38 F 160 53 20.7 90 108 248 148 45 174 140 80 
48 
Chidambara 
Vadivu 33 F 158 52 20.8 91 92 230 171 40 155 140 80 
49 Thangam 38 F 158 53 21.28 71 95 150 125 55 70 100 70 
50 Murugammal 32 F 157 57 23.17 76 90 154 145 52 73 140 80 
51 Selvi 40 F 162 59 22.4 84 130 235 150 40 165 130 80 
52 Mariyammal 39 F 152 54 23.37 76 90 176 140 50 98 138 80 
53 Poomari 32 F 142 45 22.38 75 110 158 129 56 76 120 80 
54 Ulagu 37 F 148 50 22.83 78 98 210 148 51 129 110 70 
55 Amirdhavalli 35 F 169 59 20.6 98 146 245 190 55 172 140 90 
56 fathima 37 F 165 57 20.9 94 139 221 175 55 149 160 90 
57 pottu 35 F 156 63 25.92 83 115 176 140 50 98 110 82 
58 Saroja 35 F 150 49 21.77 83 135 228 160 45 151 100 70 
59 Amudhakani 37 F 162 59 22.4 85 122 220 160 40 148 140 80 
60 chandra 35 F 151 65 28.5 82 113 174 150 50 94 110 84 
61 muthu 39 F 156 60 24.69 76 95 210 148 51 129 140 70 
62 nageswari 37 F 169 61 21.3 86 115 249 180 55 180 140 80 
63 selvi 38 F 157 52 21.09 89 112 225 151 55 154 140 90 
64 Janaki 39 F 145 48 22.8 83 105 295 152 48 234 140 80 
65 Rajeswari 38 F 160 58 22.6 83 105 240 180 48 169 140 80 
66 Mallika 39 F 152 55 23.8 75 90 230 165 43 154 140 70 
67 Pandiyammal 36 F 142 48 23.88 78 90 230 165 43 154 136 70 
68 Anitha 30 F 163 52 34.71 103 120 290 190 33 219 140 96 
69 Grace 37 F 145 66 31.42 98 145 265 180 31 198 140 94 
70 Visalatchi 30 F 165 56 20.5 89 130 235 174 52 166 140 70 
71 Saroja 32 F 161 55 21.2 80 94 162 120 55 83 120 70 
72 Lakshmi 35 F 152 67 29 76 90 236 154 39 166 140 70 
73 Pitchammal 36 F 170 62 21.4 98 150 254 174 54 180 140 80 
74 fathima 40 F 142 50 24.87 75 95 225 160 35 158 140 80 
75 kanagamani 40 F 154 47 19.83 80 89 145 135 53 65 110 70 
76 prema 32 F 145 48 22.87 89 134 210 170 52 124 140 70 
77 vijaya 33 F 164 60 22.3 90 140 225 180 48 154 150 90 
78 keeneth 34 F 145 48 22.87 72 92 164 128 54 85 120 80 
79 jasmine Banu 33 F 161 90 35.85 98 160 260 220 25 191 150 90 
80 Mareeswari 35 F 146 49 23 77 95 215 130 51 138 110 70 
81 valli 32 F 156 93 38.27 123 145 245 170 35 176 140 100 
82 Subbhulakshmi 32 F 147 48 22.22 89 120 224 158 49 143 100 70 
83 anandhi 33 F 150 80 35.55 111 134 265 177 28 201 120 94 
84 esakkiamal 34 F 154 53 22.3 91 128 215 155 50 134 150 90 
85 Mahalakshmi 34 F 153 68 29.05 80 93 202 130 48 128 120 96 
86 kanagavalli 30 F 162 60 22.8 87 105 205 148 50 125 140 90 
87 isakkithai 37 F 147 41 18.98 78 85 164 128 54 85 120 80 
88 Parvathi 33 F 148 53 25.6 80 97 219 140 50 141 120 80 
89 selvi 26 F 151 48 21.05 74 94 215 130 51 138 110 70 
90 Hameed  34 F 157 55 22.3 94 120 265 160 45 188 150 60 
91 mariyammal 29 F 165 72 26.4 103 113 222 170 30 158 150 80 
92 santhanathai 35 F 145 45 21.42 80 96 181 135 54 100 120 70 
93 mary  39 F 156 55 22.63 72 96 181 135 54 100 110 70 
94 sakthi 40 F 161 58 22.39 79 93 202 130 48 128 120 80 
95 janu 37 F 162 60 22.8 89 120 250 180 45 169 140 90 
96 priya 30 F 152 72 31.3 95 140 270 180 45 189 140 90 
97 sabari 32 F 162 62 23.66 89 130 235 150 40 165 130 90 
98 sindhuja 37 F 152 55 23.8 82 112 265 180 35 194 100 70 
99 shameem 38 F 156 63 25.92 83 115 176 140 50 120 134 70 
100 Sornalakshmi 39 F 174 66 21.7 94 140 216 145 52 174 144 90 
 
